UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)



[x]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~June 30, ~~2016~~2017



[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-31321




NAUTILUS, INC.
(Exact name of Registrant as specified in its charter)



Washington		94-3002667
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

17750 S.E. 6th Way

Vancouver, Washington 98683

(Address of principal executive offices, including zip code)

(360) 859-2900

(Registrant's telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [x] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See ~~definition~~the definitions of “large accelerated filer,” “accelerated ~~filer” and~~filer,” “smaller reporting ~~company”~~company,” and "emerging growth company" in Rule 12b-2 of the Exchange ~~Act:~~Act.

~~Large accelerated filer [ ] Accelerated filer [x] Non-accelerated filer [ ] Smaller reporting company [ ]~~

~~(do~~



Large accelerated filer [ ]	Accelerated filer [x]	Non-accelerated filer [ ]	Smaller reporting company [ ]	Emerging growth company [ ]
		(Do not check if a smaller reporting company)		If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [x]

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

The number of shares outstanding of the registrant's common stock as of ~~October~~July 31, ~~2016~~2017 was ~~31,129,383~~30,786,792 shares.

NAUTILUS, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED ~~SEPTEMBER~~JUNE 30, ~~2016~~2017



	PART I
Item 1.	Financial Statements	1
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	1916
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2826
Item 4.	Controls and Procedures	2927

	PART II
Item 1.	Legal Proceedings	2928
Item 1A.	Risk Factors	3028
Item 6.	Exhibits	3028
Signatures		3129

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

NAUTILUS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited and in thousands)


	As of						As of
	September 30, 2016			December 31, 2015			June 30, 2017			December 31, 2016
Assets
Cash and cash equivalents	$	31,169		$	30,778		$	21,811		$	47,874
Available-for-sale securities	28,081			29,998			63,624			31,743
Trade receivables, net of allowances of $102 and $918	31,266			45,155
Trade receivables, net of allowances of $290 and $170							24,220			45,458
Inventories	49,238			42,729			42,344			47,030
Prepaids and other current assets	6,993			6,888			6,020			8,020
Income taxes receivable	5,836			439			4,041			3,231
Deferred income tax assets	—			8,904
Total current assets	152,583			164,891			162,060			183,356
Property, plant and equipment, net	18,046			16,764			16,037			17,468
Goodwill	60,516			60,470			61,957			61,888
Other intangible assets, net	70,616			73,354			68,166			69,800
Deferred income tax assets, non-current							—			11
Other assets	558			433			492			543
Total assets	$	302,319		$	315,912		$	308,712		$	333,066
Liabilities and Shareholders' Equity
Trade payables	$	44,781		$	61,745		$	46,936		$	66,020
Accrued liabilities	9,379			13,027			8,746			12,892
Warranty obligations	3,773			4,753
Warranty obligations, current portion							3,266			3,500
Note payable, current portion, net of unamortized debt issuance costs of $7 and $7	15,993			15,993			15,993			15,993
Total current liabilities	73,926			95,518			74,941			98,405
Warranty obligations, non-current	4,047			3,792			3,385			3,950
Income taxes payable, non-current	2,342			4,116			2,571			2,403
Deferred income tax liabilities, non-current	13,382			18,380			17,103			16,991
Other long-term liabilities	2,994			3,144			2,358			2,481
Note payable, non-current, net of unamortized debt issuance costs of $23 and $29	51,977			63,971
Note payable, non-current, net of unamortized debt issuance costs of $18 and $21							39,982			47,979
Total liabilities	148,668			188,921			140,340			172,209
Commitments and contingencies (Note 15)
Commitments and contingencies (Note 14)
Shareholders' equity:
Common stock - no par value, 75,000 shares authorized, 31,129 and 31,005 shares issued and outstanding	5,004			796
Common stock - no par value, 75,000 shares authorized, 30,786 and 30,825 shares issued and outstanding							1,381			578
Retained earnings	150,090			127,522			167,728			161,496
Accumulated other comprehensive loss	(1,443		)	(1,327		)	(737		)	(1,217		)
Total shareholders' equity	153,651			126,991			168,372			160,857
Total liabilities and shareholders' equity	$	302,319		$	315,912		$	308,712		$	333,066

See accompanying Notes to Condensed Consolidated Financial Statements.

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited and in thousands, except per share amounts)


	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended June 30,						Six Months Ended June 30,
	2016			2015			2016			2015			2017			2016			2017			2016
Net sales	$	80,818		$	70,690		$	280,275		$	226,624		$	77,029		$	78,529		$	190,281		$	199,457
Cost of sales	41,601			34,481			132,852			105,870			38,651			36,667			90,158			91,251
Gross profit	39,217			36,209			147,423			120,754			38,378			41,862			100,123			108,206
Operating expenses:
Selling and marketing	21,394			21,742			81,284			70,193			23,628			24,711			61,293			59,890
General and administrative	6,177			5,505			21,611			15,376			7,315			7,203			14,801			15,434
Research and development	3,435			2,573			10,444			7,259			3,586			3,375			7,497			7,009
Total operating expenses	31,006			29,820			113,339			92,828			34,529			35,289			83,591			82,333
Operating income	8,211			6,389			34,084			27,926			3,849			6,573			16,532			25,873
Other income (expense):
Interest income	60			61			182			164			175			68			306			122
Interest expense	(489		)	(6		)	(1,469		)	(17		)	(412		)	(514		)	(856		)	(980		)
Other, net	211			(15		)	(49		)	(412		)	110			(136		)	63			(260		)
Total other income (expense), net	(218		)	40			(1,336		)	(265		)
Total other expense, net													(127		)	(582		)	(487		)	(1,118		)
Income from continuing operations before income taxes	7,993			6,429			32,748			27,661			3,722			5,991			16,045			24,755
Income tax expense	148			2,556			9,621			10,710			1,156			2,295			5,294			9,473
Income from continuing operations	7,845			3,873			23,127			16,951			2,566			3,696			10,751			15,282
Discontinued operations:
Loss from discontinued operations before income taxes	(308		)	(159		)	(612		)	(472		)	(29		)	(180		)	(1,655		)	(304		)
Income tax benefit from discontinued operations	(57		)	(14		)	(53		)	(405		)
Income tax expense (benefit) of discontinued operations													48			(14		)	(486		)	4
Loss from discontinued operations	(251		)	(145		)	(559		)	(67		)	(77		)	(166		)	(1,169		)	(308		)
Net income	$	7,594		$	3,728		$	22,568		$	16,884		$	2,489		$	3,530		$	9,582		$	14,974

Basic income per share from continuing operations	$	0.25		$	0.12		$	0.74		$	0.54		$	0.08		$	0.12		$	0.35		$	0.49
Basic loss per share from discontinued operations	(0.01		)	—			(0.02		)	—			—			(0.01		)	(0.04		)	(0.01		)
Basic net income per share⁽¹⁾	$	0.24		$	0.12		$	0.73		$	0.54		$	0.08		$	0.11		$	0.31		$	0.48

Diluted income per share from continuing operations	$	0.25		$	0.12		$	0.74		$	0.53		$	0.08		$	0.12		$	0.35		$	0.49
Diluted loss per share from discontinued operations	(0.01		)	—			(0.02		)	—			—			(0.01		)	(0.04		)	(0.01		)
Diluted net income per share	$	0.24		$	0.12		$	0.72		$	0.53		$	0.08		$	0.11		$	0.31		$	0.48
Shares used in per share calculations:
Basic	31,118			31,272			31,069			31,386			30,755			31,072			30,734			31,044
Diluted	31,385			31,527			31,340			31,702			31,095			31,335			31,110			31,315

⁽¹⁾ May not add due to rounding.

See accompanying Notes to Condensed Consolidated Financial Statements.

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited and in thousands)


	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended June 30,						Six Months Ended June 30,
	2016			2015			2016			2015			2017			2016			2017			2016
Net income	$	7,594		$	3,728		$	22,568		$	16,884		$	2,489		$	3,530		$	9,582		$	14,974
Other comprehensive income (loss):
Unrealized gain on available-for-sale securities, net of income tax expense of $0, $9, $16 and $14	—			10			26			23
Income (loss) on derivative securities, effective portion, net of income tax benefit (expense) of $(150), $0, $326 and $0	248			—			(539		)	—
Foreign currency translation, net of income tax (benefit) expense of $(1), $5, $(6) and $9	(45		)	(451		)	397			(803		)
Unrealized gain (loss) on available-for-sale securities, net of income tax expense (benefit) of $(5), $4, $(17) and $16													(9		)	8			(28		)	26
Gain (loss) on derivative securities, effective portion, net of income tax expense (benefit) of $(7), $(63), $65 and $(476)													(12		)	(105		)	107			(787		)
Foreign currency translation, net of income tax expense (benefit) of $2, $2, $2 and $(5)													330			(110		)	401			442
Other comprehensive income (loss)	203			(441		)	(116		)	(780		)	309			(207		)	480			(319		)
Comprehensive income	$	7,797		$	3,287		$	22,452		$	16,104		$	2,798		$	3,323		$	10,062		$	14,655

See accompanying Notes to Condensed Consolidated Financial Statements.

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited and in thousands)


	Nine Months Ended September 30,						Six Months Ended June 30,
	2016			2015			2017			2016
Cash flows from operating activities:
Income from continuing operations	$	23,127		$	16,951		$	10,751		$	15,282
Loss from discontinued operations	(559		)	(67		)	(1,169		)	(308		)
Net income	22,568			16,884			9,582			14,974
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	5,748			2,511			4,518			3,964
Provision for (benefit from) allowance for doubtful accounts	183			(118		)
Inventory lower-of-cost-or-market adjustments	72			136
Provision (benefit) for allowance for doubtful accounts							221			(876		)
Inventory lower-of-cost-or-market/NRV adjustments							258			133
Stock-based compensation expense	2,045			1,073			1,130			1,489
Loss on asset dispositions	107			289			—			127
Deferred income taxes, net of valuation allowance	5,707			9,503			67			5,629
Excess tax (benefit) deficiency related to stock-based awards	(1,852		)	1
Excess tax benefit related to stock-based awards							—			(1,729		)
Other	6			—			(65		)	5
Changes in operating assets and liabilities:
Trade receivables	13,633			7,514			20,982			26,260
Inventories	(4,716		)	(10,748		)	4,226			1,115
Prepaids and other current assets	(413		)	1,205			2,141			(445		)
Income taxes receivable	(5,397		)	(82		)	(809		)	(8,040		)
Trade payables	(15,475		)	(9,030		)	(19,477		)	(17,530		)
Accrued liabilities, including warranty obligations	(7,286		)	(630		)	(4,897		)	(2,062		)
Net cash provided by operating activities	14,930			18,508			17,877			23,014
Cash flows from investing activities:
Purchases of available-for-sale securities	(22,972		)	(55,230		)	(53,573		)	(20,305		)
Proceeds from maturities of available-for-sale securities	24,818			33,186			21,735			16,938
Proceeds from sales of available-for-sale securities	71			3,381			—			71
Acquisition of business, net of cash acquired	(3,468		)	—			—			(3,468		)
Purchases of property, plant and equipment	(3,237		)	(3,604		)
Purchases of property, plant and equipment and intangible assets							(1,084		)	(706		)
Net cash used in investing activities	(4,788		)	(22,267		)	(32,922		)	(7,470		)
Cash flows from financing activities:
Payments on long-term debt	(12,000		)	—			(8,000		)	(8,000		)
Payments for stock repurchases	—			(11,568		)	(3,427		)	—
Proceeds from exercise of stock options and employee stock plan purchases	531			1,001			490			431
Tax payments related to stock award issuances	(221		)	(775		)	(741		)	(221		)
Excess tax benefit (deficiency) related to stock-based awards	1,852			(1		)
Excess tax benefit related to stock-based awards							—			1,729
Net cash used in financing activities	(9,838		)	(11,343		)	(11,678		)	(6,061		)
Effect of exchange rate changes on cash and cash equivalents	87			(1,083		)	660			(77		)
Increase (decrease) in cash and cash equivalents	391			(16,185		)	(26,063		)	9,406
Cash and cash equivalents:
Beginning of period	30,778			45,206			47,874			30,778
End of period	$	31,169		$	29,021		$	21,811		$	40,184
Supplemental disclosure of cash flow information:
Cash paid for interest	$	(1,462	)	$	(17	)	$	851		$	975
Cash paid for income taxes, net	(11,331		)	(917		)	5,289			11,305
Supplemental disclosure of non-cash investing activities:
Capital expenditures incurred but not yet paid	$	922		$	602		$	338		$	1,701

See accompanying Notes to Condensed Consolidated Financial Statements.

NAUTILUS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(1) GENERAL INFORMATION

Basis of Consolidation and Presentation

The accompanying condensed consolidated financial statements present the financial position, results of operations and cash flows of Nautilus, Inc. and its subsidiaries, all of which are wholly owned. Intercompany transactions and balances have been eliminated in consolidation.

The accompanying condensed consolidated financial statements have not been audited. We have condensed or omitted certain information and footnote disclosures normally included in financial statements presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the disclosures contained herein are adequate to make the information presented not misleading. However, these condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, ~~2015~~2016 (the ~~“2015~~“2016 Form 10-K”).

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Further information regarding significant estimates can be found in our ~~2015~~2016 Form 10-K.

In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments necessary to present fairly our financial position as of ~~September~~June 30, ~~2016~~2017 and December 31, ~~2015,~~2016, and our results of operations and comprehensive income for the three and ~~nine~~six months ended ~~September~~June 30, ~~2016~~2017 and ~~2015~~2016, and cash flows for the ~~nine~~six months ended ~~September~~June 30, ~~2016~~2017 and ~~2015.~~2016. Interim results are not necessarily indicative of results for a full year. Our revenues typically vary seasonally and this seasonality can have a significant effect on operating results, inventory levels and working capital needs.

Unless indicated otherwise, all information regarding our operating results pertain to our continuing operations.

New Accounting Pronouncements

ASU ~~2016-15~~2017-09

In ~~August 2016,~~May 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2017-09, "Compensation - Stock Compensation (Topic 718) - Scope in Modification Accounting". ASU 2017-09 provides clarity and reduces diversity in practice and cost and complexity when applying the guidance in Topic 718 to a change to the terms or conditions of a share-based payment award. An entity should account for the effects of a modification unless all of certain criteria are met. Those criteria relate to fair value, vesting conditions and classification of the modified award. If all three conditions are the same for the modified award as for the original award, then the entity should not account for the effects of the modification. ASU 2017-09 is effective for all entities for annual periods, including interim periods within those annual periods, beginning after December 15. 2017. Early adoption is permitted, including adoption in any interim period, for public business entities for reporting periods for which financial statements have not yet been issued. We do not expect the adoption of ASU 2017-04 to have a material effect on our financial position, results of operations or cash flows.

ASU 2017-04

In January 2017, the FASB issued ASU 2017-04, "Intangibles - Goodwill and Other (Topic 350) - Simplifying the Test for Goodwill Impairment". ASU 2017-04 simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. An entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, if applicable. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The same impairment test also applies to any reporting unit with a zero or negative carrying amount. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. ASU 2017-04 is effective for public companies' fiscal years, including interim periods within those fiscal years, beginning after December 15, 2019, on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed after January 1, 2017. We do not expect the adoption of ASU 2017-04 to have a material effect on our financial position, results of operations or cash flows.

ASU 2016-15

In August 2016, the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230) - Classification of Certain Cash Receipts and Cash Payments." The amendments in ASU 2016-15 are intended to add or clarify guidance on the classification of certain cash receipts and payments in the statement of cash flows, with the intent of reducing diversity in practice for the eight (8) types of cash flows identified. ASU 2016-15 is effective for public companies' fiscal years, including interim periods within those fiscal years, beginning after December 15, 2017. Early adoption is permitted. Entities must apply the guidance retrospectively to all periods presented, but may apply it prospectively if retrospective application would be impracticable. We do not expect the adoption of ASU 2016-15 to have a material effect on our financial position, results of operations or cash flows.

ASU 2016-13

In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments." The amendments in ASU 2016-13 replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 is effective for public companies' annual periods, including interim periods within those fiscal years, beginning after December 15, 2019, using a modified-retrospective approach, with certain exceptions. Early adoption is permitted. While we do not expect the adoption of ASU 2016-13 to have a material effect on our business, we are evaluating any potential impact that adoption of ASU 2016-13 may have on our financial position, results of operations or cash flows.

ASU ~~2016-12~~

In May 2016, the FASB issued ASU 2016-12, "Revenue from Contracts with Customers (Topic 606) - Narrow-Scope Improvements and Practical Expedients." ASU 2016-12 clarifies aspects of Topic 606 related to assessing collectibility, presentation of sales taxes, non-cash consideration, and completed contracts and contract modifications at transition, while retaining the related core

principles for those areas. The effective date and transition requirements for ASU 2016-12 are the same as the effective date and transition requirements for Topic 606 (ASU 2014-09). While we do not expect the adoption of ASU 2016-12 to have a material effect on our business, we are evaluating any potential impact that adoption of ASU 2016-12 may have on our financial position, results of operations or cash flows.

~~ASU 2016-10~~

In April 2016, the FASB issued ASU 2016-10, "Revenue from Contracts with Customers (Topic 606) - Identifying Performance Obligations and Licensing." ASU 2016-10 clarifies aspects of Topic 606 related to identifying performance obligations and the licensing implementation guidance, while retaining the related core principles for those areas. The effective date and transition requirements for ASU 2016-10 are the same as the effective date and transition requirements for Topic 606 (ASU 2014-09). While we do not expect the adoption of ASU 2016-10 to have a material effect on our business, we are evaluating any potential impact that adoption of ASU 2016-10 may have on our financial position, results of operations or cash flows.

~~ASU~~ 2016-09

In March 2016, the FASB issued ASU 2016-09, "Compensation - Stock Compensation (Topic 718) - Improvements to Employee Share-Based Payment Accounting." ASU 2016-09 simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for public companies' annual periods, including interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted subject to certain requirements, and the method of application (i.e., retrospective, modified retrospective or prospective) depends on the transaction area that is being amended. Related to forfeitures, we changed our accounting treatment of forfeiture expense reversals from "at vest date" to "at forfeiture date." We ~~do not expect~~applied the guidance on a modified retrospective basis, which resulted in a cumulative effective adjustment (in thousands) of $28 reduction to beginning retained earnings. In addition, related to excess tax benefits, we recognized all current period expense through the statement of operations and presented excess tax benefits as an operating cash flow, applied prospectively, with no adjustment to prior periods. The adoption of ASU 2016-09 toin January 2017 did not have a material ~~effect~~impact on our financial position, results of operations or cash flows.

ASU 2016-02

In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)." ASU 2016-02 replaces the existing guidance in Accounting Standards Codification ("ASC") 840, Leases. The new ~~standards will~~standard would require companies and other organizations to include lease obligations on their balance sheets, including a dual approach for lessee accounting under which a lessee would account for leases as finance leases or operating leases. Both finance leases and operating leases will result in the lessee recognizing a right-of-use ("ROU") asset and a corresponding lease liability. For finance leases the lessee would recognize interest expense and amortization of the ROU asset, and for operating leases the lessee would recognize a straight-line total lease expense. Lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02 is effective for public companies' annual periods, and interim periods within those fiscal years, beginning after December 15, 2018. We are currently ~~evaluating any potential~~assessing the impact that ~~adoption of~~ ASU 2016-02 ~~may~~will have on our consolidated financial ~~position, results~~statements, and expect that the primary impact upon adoption will be the recognition, on a discounted basis, of ~~operations or cash flows.~~

~~ASU 2015-17~~

~~In November 2015,~~our minimum commitments under non-cancellable operating leases on our consolidated balance sheets resulting in the ~~FASB issued ASU 2015-17, "Income Taxes (Topic 740) - Balance Sheet Classification~~recording of ~~Deferred Taxes." ASU 2015-17 simplifies the presentation~~right of deferred income taxes, and requires that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments apply to all entities that present a classified statement of financial position, and aligns the presentation of deferred income taxuse assets and liabilities with International Financial Reporting Standards ("IFRS") IAS 1. ASU 2015-17 is effective for public companies' financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early application is permitted and may be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. Our early adoption of ASU 2015-17 in January 2016 did not have a material effect on our financial position, results of operations or cash flows. We are applying ASU 2015-17 on a prospective basis to all deferred tax liabilities and assets, and prior periods have not been retrospectively adjusted.

~~ASU 2015-16~~

In September 2015, the FASB issued ASU 2015-16, "Business Combinations (Topic 805) - Simplifying the Accounting for Measurement-Period Adjustments." ASU 2015-16 simplifies the presentation of provisional amounts reported for items in a business combination for which the accounting is incomplete by the end of the reporting period in which the combination occurs and during the measurement period have an adjustment to provisional amounts recognized. The amendments in ASU 2015-16 require an entity to recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined, and to present separately on the face of the income statement or disclose in the notes the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. ASU 2015-16 is effective for public companies' financial statements issued for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2015 on a prospective basis. Our adoption of ASU 2015-16 as of January 2016 did not have a material effect on our financial position, results of operations or cash flows.

lease liabilities.

ASU 2015-11

In July 2015, the FASB issued ASU 2015-11, “Simplifying the Measurement of Inventory (Topic 330).” ASU 2015-11 simplifies the accounting for the valuation of all inventory not accounted for using the last-in, first-out (“LIFO”) method by prescribing inventory be valued at the lower of cost and net realizable value. ASU 2015-11 is effective for public companies' annual periods, including interim periods within those fiscal years, beginning after December 15, 2016 on a prospective basis. Early adoption is permitted. ~~We do not expect the~~Our adoption of ASU 2015-11 ~~to have a material effect on our financial position, results of operations or cash flows.~~

~~ASU 2015-05~~

In April 2015, the FASB issued ASU 2015-05, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40).” ASU 2015-05 provides guidance regarding the accounting for a customer's fees paid in a cloud computing arrangement, specifically about whether a cloud computing arrangement includes a software license, and if so, how to account for the software license. ASU 2015-05 was effective for public companies' annual periods, including interim periods, beginning after December 15, 2015. Our adoption of ASU 2015-05 in January ~~2016 did not have a material effect on our financial position, results of operations or cash flows.~~

~~ASU 2014-12~~

In June 2014, the FASB issued ASU No. 2014-12, "Compensation - Stock Compensation (Topic 718)." ASU No. 2014-12 addresses accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. ASU 2014-12 indicates that, in such situations, the performance target should be treated as a performance condition and, accordingly, the performance target should not be reflected in estimating the grant-date fair value of the award. Instead, compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved. ASU 2014-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Our adoption of ASU 2014-12 in January 20162017 did not have a material effect on our financial position, results of operations or cash flows.

ASU 2014-09

In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers." ASU 2014-09 ~~clarifies the principles for recognizing revenue and develops a common revenue standard for U.S. GAAP and the International Accounting Standards Board that:~~

~~• removes inconsistencies and weaknesses in revenue requirements;~~

~~• provides a more robust framework for addressing revenue issues;~~

~~• improves comparability of~~replaces most existing revenue recognition ~~practices across entities, industries, jurisdictions~~guidance, and ~~capital markets;~~

~~• provides more useful information~~requires companies to ~~users~~recognize revenue based upon the transfer of ~~financial statements through improved disclosure requirements; and~~

~~• simplifies~~promised goods and/or services to customers in an amount that reflects the ~~preparation of financial statements by reducing the number of requirements~~consideration to which anthe entity ~~must refer.~~expects to be entitled in exchange for those

goods and/or services. In addition, the new guidance requires enhanced disclosures, including revenue recognition policies to identify performance obligations to customers and significant judgments in measurement and recognition. ASU 2014-09 is effective, as amended, for annual and interim periods beginning on or after December 15, 2017, applied retrospectively to each prior period presented or retrospectively with a cumulative effect adjustment recognized as of the adoption date. We do not plan to early adopt this new standard, and accordingly, will adopt the new standard on January 1, 2018. In addition, we have not decided on the adoption method and expect to make a final determination regarding the adoption method during third quarter 2017.

We are making progress toward completing an evaluation of the potential changes on our financial reporting resulting from adoption of the new standard, and have identified areas of possible impact for our revenue streams based on review of several significant contracts. We expect to complete the contracts evaluation and validate the impacts of accounting and disclosure changes on our business processes, controls and systems, as well as design any changes to such business processes, controls and systems, during the third quarter. We expect to implement any process changes during the fourth quarter of 2017 in preparation for adoption.

While we are continuing to assess the potential impacts under the new standard, we do not ~~expect~~believe there will be significant changes to the ~~adoption~~timing of ~~ASU 2014-09 to have a material effect~~recognition of product revenue and royalty revenue. Based on our ~~business,~~assessment to date, we ~~are still evaluating any potential impact that adoption of ASU 2014-09~~believe the new standard may have relevant impact on the timing of recognition of variable consideration and contract costs, primarily sales commissions, and on presentation of our ~~financial position, results of operations or cash flows.~~installation and services revenue.

(2) ~~BUSINESS ACQUISITION~~

On December 31, 2015, we acquired all of the outstanding capital stock of OF Holdings, Inc., sole parent of Octane Fitness, LLC ("Octane"), for an aggregate base purchase price of $115.0 million, plus net adjustments for working capital and cash acquired on the closing date. We funded the acquisition through an $80.0 million term loan and cash on hand.

For the three and nine months ended September 30, 2016, Octane contributed net sales of $16.2 million and $40.9 million, respectively. Octane contributed net income of $1.1 million for the third quarter of 2016 and $0.3 million for the first nine months of 2016. Operating results for the current three-month and year-to-date periods included amortization of acquired assets of $0.8 million and $2.3 million, respectively, and purchase accounting related inventory step-up charges of $0.1 million and $1.1 million, respectively. Working capital and other measurement period adjustments as of September 30, 2016 totaled $0.7 million and are detailed in the preliminary valuation table shown below.

Total acquisition costs incurred for the nine months ended September 30, 2016 were $0.3 million, and cumulative-to-date costs total $0.9 million. These charges were expensed as incurred in general and administrative costs.

~~Purchase Price Allocation~~

Acquired assets and liabilities were recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair value of identifiable net assets resulted in the recognition of goodwill of $58.3 million, all of which was assigned to the Retail segment, and is attributed primarily to Octane's intellectual property base, benefits of access to different markets and customers, and employee workforce. The goodwill is not expected to be deductible for income tax purposes.

The following table summarizes the preliminary fair values of the net assets acquired and liabilities assumed and measurement period adjustments since December 31, 2015, the acquisition date (in thousands):

Preliminary valuation at December 31, 2015 Measurement period adjustments Adjusted preliminary valuation at September 30, 2016
Cash $ 7,759
$ —
$ 7,759
Accounts receivable 12,507
—
12,507
Inventories 12,168
1,515
13,683
Prepaid expenses 1,028
(143 ) 885
Deferred tax assets 1,287
(527 ) 760
Property, plant and equipment 3,240
132
3,372
Intangible assets 63,100
—
63,100
Total assets acquired 101,089
977
102,066

Accounts payable 6,215
282
6,497
Accrued liabilities 1,614
(8 ) 1,606
Warranty obligations 5,550
—
5,550
Deferred tax liabilities, non-current 20,914
98
21,012
Other non-current liabilities 519
(129 ) 390
Total liabilities assumed 34,812
243
35,055

Net identifiable assets acquired 66,277
734
67,011
Goodwill 58,357
(63 ) 58,294
Net assets acquired $ 124,634
$ 671
$ 125,305

The allocation of the purchase price is preliminary and is based upon valuation information available and estimates and assumptions made as of September 30, 2016. We are still in the process of verifying data and finalizing information including valuation and recording of the assets acquired and liabilities assumed, and the resulting amount of recognized goodwill.

~~The following table sets forth the components of identifiable intangible assets and their estimated fair values and useful lives as of December 31, 2015, the acquisition date (dollars in thousands):~~

Estimated fair value Estimated useful life (years) Weighted-average amortization period (years)
Trade name - Octane Fitness $ 23,000
Indefinite N/A

Trade name - others 2,600
10 - 15 12.5
Patents 12,800
11 - 24 18
Customer relationships 24,700
10 - 15 13
Definite-lived intangible assets 40,100

Total intangible assets $ 63,100

~~Summary of Unaudited Pro Forma Information~~

The following table reflects the unaudited pro forma consolidated results of operations for the periods presented, as though the acquisition of Octane had occurred on January 1, 2015 (in thousands, except per share amounts):

(unaudited)
Three Months Ended September 30, Nine Months Ended September 30,
2016 2015 2016 2015
Net sales $ 80,818
$ 83,931
$ 280,275
$ 268,422
Net income 7,308
3,691
23,682
17,053
Net income per share:
Basic $ 0.23
$ 0.12
$ 0.76
$ 0.54
Diluted 0.23
0.12
0.76
0.54

The unaudited pro forma financial information is presented for illustrative purposes only and is not indicative of the results of operations that would have been realized if the acquisition had been completed on the date indicated, nor is it indicative of future operating results.

~~(3)~~ DISCONTINUED OPERATIONS

There was no revenue related to discontinued operations for the ~~nine~~six months ended ~~September~~June 30, ~~2016~~2017 or the year ended December 31, ~~2015.~~2016. However, we continue to have legal and accounting expenses as we work with authorities on final deregistration of certain foreign entities and product liability expenses associated with product previously sold into the Commercial channel.

During the first six months of 2017, our litigation with Biosig Instruments, Inc. ("Biosig") was settled. The ~~following table summarizes liabilities for exit costs related to~~litigation began in 2004 and alleged patent infringement in connection with our incorporation of heart rate monitors into certain cardio products of our former Commercial business. We paid Biosig $1.2 million under the settlement, and the matter was dismissed with prejudice. The settlement was expensed in discontinued operations ~~included in accrued liabilities in our Condensed Consolidated Balance Sheets (in thousands):~~

Facilities
Leases
Balance, December 31, 2015 $ 300
Payments (225 )
Balance, September 30, 2016 $ 75

~~We expect~~during the ~~lease obligations to be~~quarter ended March 31, 2017 and paid ~~out through 2016.~~during the quarter ended June 30, 2017.

~~(4)~~(3) FAIR VALUE MEASUREMENTS

Factors used in determining the fair value of financial assets and liabilities are summarized into three broad categories:

Level 1 - observable inputs such as quoted prices (unadjusted) in active liquid markets for identical securities as of the reporting date;

Level 2 - other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk; or observable market prices in markets with insufficient volume and/or infrequent transactions; and

Level 3 - significant inputs that are generally unobservable inputs for which there is little or no market data available, including our own assumptions in determining fair value.

Assets and liabilities measured at fair value on a recurring basis as of ~~September~~June 30, ~~2016~~2017 and December 31, ~~2015~~2016 were as follows (in thousands):


	September 30, 2016										June 30, 2017
	Level 1		Level 2			Level 3		Total			Level 1		Level 2		Level 3		Total
Assets:
Cash Equivalents
Money market funds	$	3,474	$	—		$	—	$	3,474		$	7,816	$	—	$	—	$	7,816
Commercial paper	—		1,999			—		1,999			—		1,998		—		1,998
Total cash equivalents	3,474		1,999			—		5,473			7,816		1,998		—		9,814
Available-for-Sale Securities
Certificates of deposit⁽¹⁾	—		25,048			—		25,048			—		19,126		—		19,126
Commercial paper											—		11,478		—		11,478
Corporate bonds	—		1,027			—		1,027			—		26,024		—		26,024
U.S. government bonds	—		2,006			—		2,006			—		6,996		—		6,996
Total available-for-sale securities	—		28,081			—		28,081			—		63,624		—		63,624

Total assets measured at fair value	$	3,474	$	30,080		$	—	$	33,554

Liabilities:
Derivatives
Interest rate swap contract	$	—	$	(865	)	$	—	$	(865	)	—		133		—		133

Total liabilities measured at fair value	$	—	$	(865	)	$	—	$	(865	)
Total assets measured at fair value											$	7,816	$	65,755	$	—	$	73,571


	December 31, 2015								December 31, 2016
	Level 1		Level 2		Level 3		Total		Level 1		Level 2			Level 3		Total
Assets:
Cash Equivalents
Money market funds	$	1	$	—	$	—	$	1	$	9,635	$	—		$	—	$	9,635
Corporate bonds	—		733		—		733
Commercial paper									—		3,999			—		3,999
Total cash equivalents	1		733		—		734		9,635		3,999			—		13,634

Available-for-Sale Securities
Certificates of deposit⁽¹⁾	—		25,234		—		25,234		—		22,820			—		22,820
Corporate bonds	—		4,764		—		4,764		—		6,922			—		6,922
U.S. government bonds									—		2,001			—		2,001
Total available-for-sale securities	—		29,998		—		29,998		—		31,743			—		31,743

Total assets measured at fair value	$	1	$	30,731	$	—	$	30,732	$	9,635	$	35,742		$	—	$	45,377

Liabilities:
Derivatives
Interest rate swap contract									$	—	$	(38	)	$	—	$	(38	)

Total liabilities measured at fair value									$	—	$	(38	)	$	—	$	(38	)

⁽¹⁾ All certificates of deposit are within current FDIC insurance limits.

~~We did not have any liabilities measured at fair value on a recurring basis as of December 31, 2015.~~

For our assets measured at fair value on a recurring basis, we recognize transfers between levels at the actual date of the event or change in circumstance that caused the transfer. There were no transfers between levels during the ~~three and nine~~six months ended ~~September~~June 30, ~~2016,~~2017, nor for the year ended December 31, ~~2015.~~2016.

We did not have any changes to our valuation techniques during the ~~three and nine~~six months ended ~~September~~June 30, ~~2016,~~2017, nor for the year ended December 31, ~~2015.~~2016.

We classify our marketable securities as available-for-sale and, accordingly, record them at fair value. Level 1 investment valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 investment valuations are obtained from inputs, other than quoted market prices in active markets for identical assets, that are directly or indirectly observable in the marketplace and quoted prices in markets with limited volume or infrequent transactions. The factors or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. Unrealized holding gains and losses are excluded from earnings and are reported net of tax in comprehensive income until realized.

The fair value of our interest rate swap contract is calculated as the present value of estimated future cash flows using discount factors derived from relevant Level 2 market inputs, including forward curves and volatility levels.

We recognize or disclose the fair value of certain assets, such as non-financial assets, primarily property, plant and equipment, goodwill, other intangible assets and certain other long-lived assets in connection with impairment evaluations. All of our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy. We did not perform any valuations on assets or liabilities that are valued at fair value on a nonrecurring basis during the first ~~nine~~six months of ~~2016.~~2017. During the fourth quarter of ~~2015,~~2016, we performed our annual goodwill and indefinite-lived trade names impairment analyses effective as of October 1, ~~2015.~~2016. During the ~~nine~~six months ended ~~September~~June 30, ~~2016~~2017 and the year ended December 31, ~~2015,~~2016, we did not record any other-than-temporary impairments on our financial assets required to be measured at fair value on a nonrecurring basis.

The carrying values of cash and cash equivalents, trade receivables, prepaids and other current assets, trade payables and accrued liabilities approximate fair value due to their short maturities. The carrying value of our term loan approximates its fair value and falls under Level 2 of the fair value hierarchy, as the interest rate is variable and based on current market rates.

~~(5)~~(4) DERIVATIVES

From time to time, we enter into interest rate swaps to fix a portion of our interest expense. We do not enter into derivative instruments for any purpose other than to manage interest rate exposure to fluctuations in the one-month LIBOR benchmark. That is, we do not engage in interest rate speculation using derivative instruments.

As of ~~September~~June 30, ~~2016,~~2017, we had a ~~$68.0~~$56.0 million interest rate swap outstanding with JPMorgan Chase Bank, N.A. This interest rate swap matures on December 31, 2020 and has a fixed rate of 1.42% per annum. The variable rate on the interest rate swap is the one-month LIBOR benchmark. At ~~September~~June 30, ~~2016,~~2017, the one-month LIBOR rate was ~~0.52%~~1.04%.

We typically designate all interest rate swaps as cash flow hedges and, accordingly, record the change in fair value for the effective portion of these interest rate swaps in accumulated other comprehensive income rather than current period earnings until the underlying hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. For the three and ~~nine~~six months ended ~~September~~June 30, 2017 and 2016, there was no ineffectiveness. As of ~~September~~June 30, ~~2016,~~2017, we expect to reclassify a ~~loss~~gain of ~~$0.6~~$0.1 million from accumulated other comprehensive ~~loss~~income to earnings within the next twelve months.

The fair value of our derivative instruments was included in our ~~Condensed Consolidated Balance Sheets~~condensed consolidated balance sheets as follows (in thousands):


	Balance Sheet Classification		As of							Balance Sheet Classification		As of
		September 30, 2016				December 31, 2015				Balance Sheet Classification	June 30, 2017				December 31, 2016
Derivatives instruments designated as cash flow hedges:
Interest rate swap contract	Balance Sheet Classification	Accrued liabilities		$	550			$	—		Prepaids and other current assets		$	133			$	—
	Other long-term liabilities		315				—			Accrued liabilities		—				38
			$	865			$	—				$	133			$	38

The effect of derivative instruments on our ~~Condensed Consolidated Statements~~condensed consolidated statements of ~~Operations~~operations was as follows (in thousands):

Statement of Operations Classification Three Months Ended September 30, Nine Months Ended September 30,
2016 2015 2016 2015
Derivatives instruments designated as
cash flow hedges:

Gain (loss) recognized in other comprehensive income before reclassifications --- $ 84
$ —
$ (896 ) $ —
Loss reclassified from accumulated other comprehensive income to earnings for the effective portion Interest expense $ (167 ) $ —
$ (480 ) $ —
Related tax effect Income tax benefit $ 3
$ —
$ 123
$ —



	Statement of Operations Classification	Three Months Ended June 30,						Six Months Ended June 30,
	Statement of Operations Classification	2017			2016			2017			2016
Derivatives instruments designated as cash flow hedges:
Loss recognized in other comprehensive income before reclassifications	---	$	(53	)	$	(219	)	$	(2	)	$	(980	)
Loss reclassified from accumulated other comprehensive income to earnings for the effective portion	Interest expense	$	(61	)	$	(185	)	$	(163	)	$	(313	)
Income tax benefit	Income tax expense	$	20		$	71		$	54		$	120

For additional information related to our derivatives, see Notes 3 and 10.

~~(6)~~(5) INVENTORIES

Inventories are stated at the lower of cost ~~or market,~~and net realizable value, with cost determined based on the first-in, first-out method. Our inventories consisted of the following (in thousands):


	As of				As of
	September 30, 2016		December 31, 2015		June 30, 2017		December 31, 2016
Finished goods	$	45,593	$	39,115	$	38,282	$	43,130
Parts and components	3,645		3,614		4,062		3,900
Total inventories	$	49,238	$	42,729	$	42,344	$	47,030

~~(7)~~(6) PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following (in thousands):


	Estimated Useful Life (in years)			As of						Estimated Useful Life (in years)			As of
	Estimated Useful Life (in years)			September 30, 2016			December 31, 2015			Estimated Useful Life (in years)			June 30, 2017			December 31, 2016
Automobiles	5	to	6	$	139		$	139		5	to	6	$	139		$	139
Leasehold improvements	4	to	20	3,256			3,397			4	to	20	3,426			3,388
Computer software and equipment	3	to	7	25,706			23,991			3	to	7	26,059			25,899
Machinery and equipment	3	to	5	12,540			10,867			3	to	5	13,971			13,085
Furniture and fixtures	5	to	20	2,062			1,605			5	to	20	2,238			2,238
Work in progress⁽¹⁾	N/A			1,308			1,655			N/A			893			768
Total cost				45,011			41,654						46,726			45,517
Accumulated depreciation				(26,965		)	(24,890		)				(30,689		)	(28,049		)
Total property, plant and equipment, net				$	18,046		$	16,764					$	16,037		$	17,468

⁽¹⁾ Work in progress includes production tooling and ~~equipment, and internal use software development.~~computer software.

~~(8)~~(7) GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The rollforward of goodwill was as follows (in thousands):

Direct Retail Total
Balance, January 1, 2015 $ 2,520
$ —
$ 2,520
Currency exchange rate adjustment (407 ) —
(407 )
Business acquisition (Note 2) —
58,357
58,357
Balance, December 31, 2015 2,113
58,357
60,470
Currency exchange rate adjustment 117
(8 ) 109
Business acquisition (Note 2) - measurement period adjustments —
(63 ) (63 )
Balance, September 30, 2016 $ 2,230
$ 58,286
$ 60,516



	Direct		Retail			Total
Balance, January 1, 2016	$	2,113	$	58,357		$	60,470
Currency exchange rate adjustment	67		3			70
Business acquisition - measurement period adjustments	—		1,348			1,348
Balance, December 31, 2016	2,180		59,708			61,888
Currency exchange rate adjustment	77		(8		)	69
Balance, June 30, 2017	$	2,257	$	59,700		$	61,957

Other Intangible Assets

Other intangible assets consisted of the following (in thousands):


	Estimated Useful Life (in years)			As of						Estimated Useful Life (in years)			As of
	Estimated Useful Life (in years)			September 30, 2016			December 31, 2015			Estimated Useful Life (in years)			June 30, 2017			December 31, 2016
Indefinite-lived trademarks	N/A			$	32,052		$	32,052		N/A			$	32,052		$	32,052
Definite-lived trademarks	10	to	15	2,600			2,600			10	to	15	2,600			2,600
Patents	8	to	24	31,487			31,487			8	to	24	31,487			31,487
Customer relationships	10	to	15	24,700			24,700			10	to	15	24,700			24,700
				90,839			90,839						90,839			90,839
Accumulated amortization - definite-lived intangible assets				(20,223		)	(17,485		)				(22,673		)	(21,039		)
Other intangible assets, net				$	70,616		$	73,354					$	68,166		$	69,800

Amortization expense was as follows (in thousands):

Three Months Ended September 30, Nine Months Ended September 30,
2016 2015 2016 2015
Amortization expense $ 817
$ 188
$ 2,738
$ 657



	Three Months Ended June 30,				Six Months Ended June 30,
	2017		2016		2017		2016
Amortization expense	$	817	$	961	$	1,634	$	1,921

Future amortization of definite-lived intangible assets is as follows (in thousands):


Remainder of 2016	$	816
2017	3,256
Remainder of 2017			$	1,622
2018	3,164		3,164
2019	3,134		3,134
2020	3,108		3,108
2021			3,078
Thereafter	25,086		22,008
	$	38,564	$	36,114

~~(9)~~(8) ACCRUED LIABILITIES

Accrued liabilities consisted of the following (in thousands):


	As of				As of
	September 30, 2016		December 31, 2015		June 30, 2017		December 31, 2016
Payroll and related liabilities	$	3,282	$	6,556	$	3,833	$	4,579
Other	6,097		6,471		4,913		8,313
Total accrued liabilities	$	9,379	$	13,027	$	8,746	$	12,892

~~(10)~~(9) PRODUCT WARRANTIES

Our products carry defined warranties for defects in materials or workmanship which, according to their terms, generally obligate us to pay the costs of supplying and shipping replacement parts to customers and, in certain instances, pay for labor and other costs to service products. Outstanding product warranty periods range from thirty days to, in limited circumstances, the lifetime of certain product components. We record a liability at the time of sale for the estimated costs of fulfilling future warranty claims. If necessary, we adjust the liability for specific warranty-related matters when they become known and are reasonably estimable. Estimated warranty expense is included in cost of sales, based on historical warranty claim experience and available product quality data. Warranty expense is affected by the performance of new products, significant manufacturing or design defects not discovered until after the product is delivered to the customer, product failure rates, and higher or lower than expected repair costs. If warranty expense differs from previous estimates, or if circumstances change such that the assumptions inherent in previous estimates are no longer valid, the amount of product warranty obligations is adjusted accordingly.

Changes in our product warranty obligations were as follows (in thousands):


	Nine Months Ended September 30,						Six Months Ended June 30,
	2016			2015			2017			2016
Balance, beginning of period	$	8,545		$	2,246		$	7,450		$	8,545
Accruals	2,132			1,845			1,470			1,644
Payments	(2,857		)	(1,433		)	(2,269		)	(2,060		)
Balance, end of period	$	7,820		$	2,658		$	6,651		$	8,129

~~(11)~~(10) ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Accumulated other comprehensive income (loss), net of applicable taxes, reported on our Condensed Consolidated Balance Sheets consists of unrealized holding gains and losses on available-for-sale securities, effective portions of gains and losses of derivative securities designated as cash flow hedges, and foreign currency translation adjustments. The following tables set forth the changes in accumulated other comprehensive income (loss), net of tax (in thousands) for the periods presented:


	Unrealized Gain on Available-for-Sale Securities		Gain (Loss) on Derivative Securities (Effective Portion)			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)			Unrealized Loss on Available-for-Sale Securities			Gain (Loss) on Derivative Securities (Effective Portion)			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)
Balance, June 30, 2016	$	10	$	(787	)	$	(869	)	$	(1,646	)
Balance, April 1, 2017												$	(27	)	$	95		$	(1,114	)	$	(1,046	)
Current period other comprehensive income (loss) before reclassifications	—		84			(45		)	39			(9		)	(53		)	330			268
Reclassification of amounts to earnings	—		164			—			164			—			41			—			41
Net other comprehensive income (loss) during period	—		248			(45		)	203			(9		)	(12		)	330			309
Balance, September 30, 2016	$	10	$	(539	)	$	(914	)	$	(1,443	)
Balance, June 30, 2017												$	(36	)	$	83		$	(784	)	$	(737	)


	Unrealized Gain (Loss) on Available-for-Sale Securities			Loss on Derivative Securities (Effective Portion)			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Loss			Unrealized Loss on Available-for-Sale Securities			Gain (Loss) on Derivative Securities (Effective Portion)			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2015	$	(16	)	$	—		$	(1,311	)	$	(1,327	)
Balance, January 1, 2017													$	(8	)	$	(24	)	$	(1,185	)	$	(1,217	)
Current period other comprehensive income (loss) before reclassifications	26			(896		)	397			(473		)	(28		)	(2		)	401			371
Reclassification of amounts to earnings	—			357			—			357			—			109			—			109
Net other comprehensive income (loss) during period	26			(539		)	397			(116		)	(28		)	107			401			480
Balance, September 30, 2016	$	10		$	(539	)	$	(914	)	$	(1,443	)
Balance, June 30, 2017													$	(36	)	$	83		$	(784	)	$	(737	)

Unrealized Gain (Loss) on Available-for-Sale Securities Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss
Balance, June 30, 2015 $ (5 ) $ (642 ) $ (647 )
Current period other comprehensive income (loss) 10
(451 ) (441 )
Balance, September 30, 2015 $ 5
$ (1,093 ) $ (1,088 )



	Unrealized Gain on Available-for-Sale Securities		Loss on Derivative Securities (Effective Portion)			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Loss
Balance, April 1, 2016	$	2	$	(682	)	$	(759	)	$	(1,439	)
Current period other comprehensive income (loss) before reclassifications	8		(219		)	(110		)	(321		)
Reclassification of amounts to earnings	—		114			—			114
Net other comprehensive income (loss) during period	8		(105		)	(110		)	(207		)
Balance, June 30, 2016	$	10	$	(787	)	$	(869	)	$	(1,646	)

Unrealized Gain (Loss) on Available-for-Sale Securities Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss
Balance, December 31, 2014 $ (18 ) $ (290 ) $ (308 )
Current period other comprehensive income (loss) 23
(803 ) (780 )
Balance, September 30, 2015 $ 5
$ (1,093 ) $ (1,088 )



	Unrealized Gain (Loss) on Available-for-Sale Securities			Loss on Derivative Securities (Effective Portion)			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Loss
Balance, January 1, 2016	$	(16	)	$	—		$	(1,311	)	$	(1,327	)
Current period other comprehensive income (loss) before reclassifications	26			(980		)	442			(512		)
Reclassification of amounts to earnings	—			193			—			193
Net other comprehensive income (loss) during period	26			(787		)	442			(319		)
Balance, June 30, 2016	$	10		$	(787	)	$	(869	)	$	(1,646	)

~~(12)~~(11) STOCK REPURCHASE PROGRAM

On November 3, 2014, our Board of Directors approved a stock repurchase program that authorized us to repurchase up to $15.0 million of our outstanding common stock from time to time during the ensuing period of 24 months. On May 4, 2016, our Board of Directors ~~approved an expansion~~authorized the repurchase of ~~our share repurchase program that authorized us to repurchase~~ up to ~~an additional~~ $10.0 million of our outstanding common stock from time to time ~~during~~through May 4, 2018.

On April 25, 2017, our Board of Directors authorized an additional $15.0 million share repurchase program, bringing the ~~period~~total authorization under existing programs to $25.0 million. Under the new program, shares of ~~24 months following such approval.~~our common stock may be repurchased from time to time through April 25, 2019. Repurchases may be made in open market transactions at prevailing prices, in privately negotiated transactions, or by other means in accordance with federal securities laws. Share repurchases ~~are~~will be funded from existing cash balances, and ~~the~~ repurchased shares ~~are~~will be retired and returned to unissued authorized shares.

As of ~~September~~June 30, ~~2016, a total of $13.4 million remained available for future repurchases. The repurchase program expires on November 3, 2016 as to the approximately $3.4~~2017, there was $19.6 million remaining available for repurchases under the ~~original $15.0 million~~share repurchase programs.

~~authorization. The repurchase program expires on May 4, 2018 as to the $10.0 million available for~~Cumulative repurchases ~~under the $10.0 million expansion.~~

~~There were no repurchases during the three and nine months ended September 30, 2016. Repurchases~~ pursuant to the ~~program were~~programs are as follows:

Quarter Ended Number of Shares Repurchased Amount Average Price Per Share
March 31, 2015 133,877 $1,995,982 $14.91
September 30, 2015 577,831 9,571,545 16.56
Totals to Date 711,708 $11,567,527 $16.25



Quarter Ended	Number of Shares	Repurchased Amount	Average Price Per Share
December 31, 2016	120,996	$1,957,882	$16.18
March 31, 2017	218,515	3,426,959	15.68
Totals-to-Date	339,511	$5,384,841	$15.86

~~(13)~~(12) INCOME PER SHARE

Basic per share amounts were computed using the weighted average number of common shares outstanding. Diluted per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method. The weighted average numbers of shares outstanding used to compute income per share were as follows (in thousands):


	Three Months Ended September 30,		Nine Months Ended September 30,		Three Months Ended June 30,		Six Months Ended June 30,
	2016	2015	2016	2015	2017	2016	2017	2016
Shares used to calculate basic income per share	31,118	31,272	31,069	31,386	30,755	31,072	30,734	31,044
Dilutive effect of outstanding stock options, performance stock units and restricted stock units	267	255	271	316	340	263	376	271
Shares used to calculate diluted income per share	31,385	31,527	31,340	31,702	31,095	31,335	31,110	31,315

The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted income per ~~share~~share. In the case of stock options, this is because the average market price did not exceed the exercise price. These shares may be dilutive potential common shares in the future (in thousands):

Three Months Ended September 30, Nine Months Ended September 30,
2016 2015 2016 2015
Stock options 4
7
11
10



	Three Months Ended June 30,		Six Months Ended June 30,
	2017	2016	2017	2016
Stock options	7	11	8	11

~~(14)~~(13) SEGMENT AND ENTERPRISE-WIDE INFORMATION

~~We operate in three segments - Direct, Retail, and Commercial and Specialty. Based on the aggregation criteria of~~In accordance with FASB ASC ~~280-10,~~280, Segment Reporting, we determined that ~~two of the operating segments (Retail and Commercial and Specialty) can be aggregated due to these segments having similar economic and other characteristics. As a result,~~ we have two ~~reportable~~operating segments - Direct and Retail. ~~This financial reporting structure was effective as of December 31, 2015,~~There have been no changes in our operating segments during the ~~date on which we acquired Octane.~~six months ended June 30, 2017.

We evaluate performance using several factors, of which the primary financial measures are net sales and reportable segment contribution. Contribution is the measure of profit or loss, defined as net sales less product costs and directly attributable expenses. Directly attributable expenses include selling and marketing expenses, general and administrative expenses, and research and development expenses that are directly related to segment operations. Segment assets are those directly assigned to an operating segment's operations, primarily accounts receivable, inventories, goodwill and other intangible assets. Unallocated assets primarily include cash and cash equivalents, available-for-sale securities, derivative securities, shared information technology infrastructure, distribution centers, corporate headquarters, prepaids and other current assets, deferred income tax assets and other assets. Capital expenditures directly attributable to the Direct and Retail segments were not significant in any period.

Following is summary information by reportable segment (in thousands):


	Three Months Ended September 30,							Nine Months Ended September 30,						Three Months Ended June 30,								Six Months Ended June 30,
	2016			2015				2016			2015			2017					2016			2017			2016
Net sales:
Direct	$	33,710		$	42,876			$	159,884		$	158,595		$	39,111				$	44,940		$	113,814		$	126,174
Retail	46,223			25,730				117,939			64,424			37,083					32,911			74,888			71,716
Royalty	885			2,084				2,452			3,605			835					678			1,579			1,567
Consolidated net sales	$	80,818		$	70,690			$	280,275		$	226,624		$	77,029				$	78,529		$	190,281		$	199,457
Contribution:
Direct	$	2,584		$	5,394			$	31,253		$	30,071		$	2,519				$	7,525		$	17,852		$	28,669
Retail	9,164			3,224				17,225			5,900			6,097					4,117			8,309			8,061
Royalty	871			2,084				2,419			3,605			835					678			1,568			1,548
Consolidated contribution	$	12,619		$	10,702			$	50,897		$	39,576		$	9,451				$	12,320		$	27,729		$	38,278

Reconciliation of consolidated contribution to income from continuing operations:
Consolidated contribution	$	12,619		$	10,702			$	50,897		$	39,576		$	9,451				$	12,320		$	27,729		$	38,278
Amounts not directly related to segments:
Operating expenses	(4,408		)	(4,313		)		(16,813		)	(11,650		)	(5,602		)	—		(5,747		)	(11,197		)	(12,405		)
Other income (expense), net	(218		)	40			��	(1,336		)	(265		)
Other expense, net														(127		)	—		(582		)	(487		)	(1,118		)
Income tax expense	(148		)	(2,556		)		(9,621		)	(10,710		)	(1,156		)	$	—	(2,295		)	(5,294		)	(9,473		)
Income from continuing operations	$	7,845		$	3,873			$	23,127		$	16,951		$	2,566				$	3,696		$	10,751		$	15,282

There was no material change in the allocation of assets by segment during the first ~~nine~~six months of ~~2016~~2017 and, accordingly, assets by segment are not presented.

For the three ~~and nine~~ months ended ~~September~~June 30, 2017 and 2016, Amazon.com accounted for ~~17.2%~~13.9% and ~~12.1%~~12.3% , respectively, of total net sales. ~~For the third quarter of 2015,~~ Amazon.com ~~represented 13.6% of our total net sales,~~accounted for 11.0% and ~~no customer represented~~ 10.0% ~~or more~~, respectively, of total net sales for the ~~first nine~~six months ~~of 2015.~~ended June 30, 2017 and 2016.

~~(15)~~(14) COMMITMENTS AND CONTINGENCIES

Guarantees, Commitments and Off-Balance Sheet Arrangements

As of ~~September~~June 30, ~~2016~~2017, we had ~~approximately $0.6 million in~~no standby letters of ~~credit with certain vendors expiring April 2017.~~credit.

We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of ~~September~~June 30, ~~2016~~2017, we had approximately ~~$35.0~~$45.4 million in noncancelable market-based purchase obligations, primarily for inventory purchases expected to be received within the next twelve months. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses.

In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

The nature and terms of these indemnification obligations vary from contract to contract, and generally a maximum obligation is not stated within the agreements. We hold insurance policies that mitigate potential losses arising from certain types of indemnification obligations. Management does not deem these obligations to be significant to our financial position, results of operations or cash flows, and therefore, no related liabilities were recorded as of ~~September~~June 30, ~~2016.~~2017.

Legal Matters

~~In 2004, we were sued~~As described in our Quarterly Report on Form 10-Q for the ~~Southern District of New York~~quarter ended March 31, 2017, a lawsuit originally filed by ~~BioSig~~Biosig Instruments, Inc. in 2004 for alleged patent infringement ~~in connection with our incorporation~~was settled effective as of ~~heart rate monitors into certain cardio products. No significant activity in~~March 28, 2017. We paid $1.2 million under the litigation occurred until 2008. In 2012, the United States District Court granted summary judgment to us on grounds that BioSig’s patents were invalid as a matter of law. BioSig appealed the grant of summary judgmentsettlement, and ~~in April 2013, the United States Court of Appeals for the Federal Circuit reversed the District Court’s decision on summary judgment and remanded the case to~~ the District Court ~~for further proceedings. On January 10, 2014,~~dismissed the ~~U. S. Supreme Court granted our petition for a writ of certiorari to address~~suit with prejudice. The settlement was expensed in discontinued operations during the ~~legal standard applied by~~quarter ended March 31, 2017 and paid during the ~~Federal Circuit in determining whether the patents may be valid under applicable law. The case was argued before the Supreme Court on April 28, 2014. By decision dated~~quarter ended June 2, 2014, the Supreme Court unanimously reversed the Federal Circuit, holding that its standard of when a patent may be “indefinite” was incorrect and remanding to the Federal Circuit for reconsideration under the correct standard. The remand hearing in the Federal Circuit was held on October 29, 2014. By decision dated April 27, 2015, the same panel of the Federal Circuit affirmed its earlier reversal of the District Court’s decision on summary judgment. On May 27, 2015, we filed a petition for a rehearing en banc in the Federal Circuit, which was denied on August 4, 2015 and a Petition for Review by the U. S. Supreme Court which was also denied. The case has been returned to the District Court, and the parties are currently engaged in discovery and other pre-trial motion practice. We do not believe that our use of heart rate monitors utilized or purchased from third parties, and otherwise, infringes the BioSig patents.30, 2017.

In addition to the matter described above, from time to time, we may be involved in various claims, lawsuits and other proceedings. These legal and tax proceedings involve uncertainty as to the eventual outcomes and losses which may be realized when one or more future events occur or fail to occur.

Litigation and jury verdicts are, to some degree, inherently unpredictable, and although we have determined that a loss is not probable in connection with any current legal proceeding, it is reasonably possible that a loss may be incurred in connection with proceedings to which we are a party. Assessment of whether incurrence of a loss is probable, or a reasonable possibility, in connection with a particular proceeding, and estimation of the loss, or a range of loss, involves complex judgments and numerous uncertainties. Management is unable to estimate a range of reasonably possible losses related to litigation in which the damages sought are indeterminate, or the legal and factual basis for the relevant claims have not been developed with specificity. As such, zero liability is recorded as of ~~September~~June 30, ~~2016.~~2017.

We regularly monitor our estimated exposure to these contingencies and, as additional information becomes known, may change our estimates accordingly. We evaluate, on a quarterly basis, developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would make a loss probable or reasonably possible, and whether the amount of a probable or reasonably possible loss is estimable. Among other factors, we evaluate the advice of internal and external counsel, the outcomes from similar litigation, current status of the lawsuits (including settlement initiatives), legislative developments and other factors. Due to the numerous variables associated with these judgments and assumptions, both the precision and reliability of the resulting estimates of the related loss contingencies are subject to substantial uncertainties.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis is based upon our financial statements as of the dates and for the periods presented in this section. You should read this discussion and analysis in conjunction with the financial statements and notes thereto found in Part I, Item 1 of this Form 10-Q and our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, ~~2015~~2016 (the ~~“2015~~“2016 Form 10-K”). All references to the ~~third~~second quarter and first ~~nine~~six months of ~~2016~~2017 and ~~2015~~2016 mean the three and ~~nine-month~~six-month periods ended ~~September~~June 30, ~~2016~~2017 and ~~2015,~~2016, respectively. Unless the context otherwise requires, “Nautilus,” “we,” “us” and “our” refer to Nautilus, Inc. and its subsidiaries. Unless indicated otherwise, all information regarding our operating results pertains to our continuing operations.

Our results of operations may vary significantly from period-to-period. Our revenues typically fluctuate due to the seasonality of our industry, customer buying patterns, product innovation, the nature and level of competition for health and fitness products, our ability to procure products to meet customer demand, the level of spending on, and effectiveness of, our media and advertising programs and our ability to attract new customers and maintain existing sales relationships. In addition, our revenues are highly susceptible to economic factors, including, among other things, the overall condition of the economy and the availability of consumer credit in both the ~~United States~~U.S. and Canada. Our profit margins may vary in response to the aforementioned factors and our ability to manage product costs. Profit margins may also be affected by fluctuations in the costs or availability of materials used to manufacture our products, costs associated with acquisition or license of products and technologies, product warranty costs, the cost of fuel, and changes in costs of other distribution or manufacturing-related services. Our operating profits or losses may also be affected by the efficiency and effectiveness of our organization. Historically, our operating expenses have been influenced by media costs to produce and distribute advertisements of our products on television, the Internet and other media, facility costs, operating costs of our information and communications systems, product supply chain management, customer support and new product development activities. In addition, our operating expenses have been affected from time-to-time by asset impairment charges, restructuring charges and other significant unusual or infrequent expenses.

As a result of the above and other factors, our period-to-period operating results may not be indicative of future performance. You should not place undue reliance on our operating results and should consider our prospects in light of the risks, expenses and difficulties typically encountered by us and other companies, both within and outside our industry. We may not be able to successfully address these risks and difficulties and, consequently, we cannot assure you of any future growth or profitability. For more information, see our discussion of risk factors located at Part I, Item 1A of our ~~2015~~2016 Form 10-K.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "plan," "expect," "aim," "believe," "project," "intend," "estimate," "will," "should," "could," and other terms of similar meaning typically identify forward-looking statements. Forward-looking statements include any statements related to our future business and financial performance; anticipated fluctuations in net sales due to seasonality; plans and expectations regarding gross and operating margins; plans and expectations regarding research and development expenses and capital expenditures; anticipated losses from discontinued operations; ~~the anticipated outcome of litigation to which we are a party;~~ results of media investment in the Direct segment; plans for new product introductions and anticipated demand for our new and existing products; and statements regarding our inventory and working capital requirements and the sufficiency of our financial resources. These forward-looking statements, and others we make from time-to-time, are subject to a number of risks and uncertainties. Many factors could cause actual results to differ materially from those projected in forward-looking statements, including our ability to timely acquire inventory that meets our quality control standards from sole source foreign manufacturers at acceptable costs, the effectiveness, availability and price of media time consistent with our cost and audience profile parameters, greater than anticipated costs associated with launch of new products, our ability to successfully integrate acquired businesses, a decline in consumer spending due to unfavorable economic conditions, softness in the retail marketplace, an adverse change in the availability of credit for our customers who finance their purchases, our ability to pass along vendor raw material price increases and increased shipping costs, our ability to effectively develop, market and sell future products, our ability to protect our intellectual property, the introduction of competing products, and our ability to get foreign-sourced product through customs in a timely manner. Additional assumptions, risks and uncertainties are described in Part I, Item 1A, "Risk Factors," in our ~~2015~~2016 Form 10-K as supplemented or modified in our quarterly reports on Form 10-Q. We do not undertake any duty to update forward-looking statements after the date they are made or conform them to actual results or to changes in circumstances or expectations.

Overview

We are committed to providing innovative, quality solutions to help people achieve a fit and healthy lifestyle. Our principal business activities include designing, developing, sourcing and marketing high-quality cardio and strength fitness products and related accessories for consumer use, primarily in the ~~United States,~~U.S., Canada and Europe. Our products are sold under some of the most-recognized brand names in the fitness industry: Nautilus^®, Bowflex^®, Octane Fitness^®, Schwinn^®and Universal^®.

We market our products through two distinct distribution channels, Direct and Retail, which we consider to be separate business segments. Our Direct business offers products directly to consumers through television advertising, catalogs and the Internet. Our Retail business offers our products through a network of independent retail companies and specialty retailers with stores and websites located in the ~~United States~~U.S. and internationally. We also derive a portion of our revenue from the licensing of our brands and intellectual property.

Net sales for the first ~~nine~~six months of ~~2016~~2017 were ~~$280.3~~$190.3 million, ~~an increase~~a decrease of ~~$53.7~~$9.2 million, or ~~23.7%~~4.6%, as compared to net sales of ~~$226.6~~$199.5 million for the first ~~nine~~six months of ~~2015.~~2016. Net sales of our Direct segment ~~increased $1.3~~decreased $12.4 million, or ~~0.8%~~9.8%, in the first ~~nine~~six months of ~~2016,~~2017, compared to the first ~~nine~~six months of ~~2015,~~2016, primarily due to ~~increased consumer demand for our cardio products.~~a decline in TreadClimber^® sales. Net sales of our Retail segment increased by ~~$53.5~~$3.2 million, or ~~83.1%~~4.4%, in the first ~~nine~~six months of ~~2016,~~2017, compared to the first ~~nine~~six months of ~~2015, primarily due to the addition of Octane sales, coupled with strong organic Retail sales growth~~2016, reflecting increases for both traditional and e-commerce customers across ~~both cardio and strength~~multiple product ~~offerings.~~categories.

Gross profit for the first ~~nine~~six months of ~~2016~~2017 was ~~$147.4~~$100.1 million, or 52.6% of net sales, ~~an increase~~a decrease of ~~$26.7~~$8.1 million, or ~~22.1%~~7.5%, as compared to gross profit of ~~$120.8~~$108.2 million, or ~~53.3%~~54.3% of net sales, for the first ~~nine~~six months of ~~2015.~~2016. The ~~increase~~decrease in gross profit dollars was primarily due to the ~~increase~~decrease in net sales. Gross margin percentage points decreased 1.7%, due to an unfavorable segment mix, reflecting an increased percentage of Retail sales, ~~as well as~~and a decline in the Direct channel margin, ~~improvements.~~resulting from higher discounting on TreadClimber^® products.

Operating expenses for the first ~~nine~~six months of ~~2016~~2017 were ~~$113.3~~$83.6 million, an increase of ~~$20.5~~$1.3 million, or ~~22.1%~~1.5%, as compared to operating expenses of ~~$92.8~~$82.3 million for the first ~~nine~~six months of ~~2015.~~2016. The ~~growth~~rise in operating expenses was primarily related to ~~the incremental operating expenses of the acquired Octane business.~~increased sales and marketing, reflecting higher media spending.

Operating income for the first ~~nine~~six months of ~~2016~~2017 was ~~$34.1~~$16.5 million, ~~an increase~~a decrease of ~~$6.2~~$9.3 million, or ~~22.1%~~36.1%, as compared to operating income of ~~$27.9~~$25.9 million for the first ~~nine~~six months of ~~2015.~~2016. The ~~improvement~~decrease in operating ~~results~~income for the first ~~nine~~six months of ~~2016~~2017 compared to the first ~~nine~~six months of ~~2015~~2016 was driven primarily by ~~higher~~the lower net sales and ~~improved~~ gross ~~profits.~~margin dollars, and increased sales and marketing spending.

Income from continuing operations was ~~$23.1~~$10.8 million for the first ~~nine~~six months of ~~2016,~~2017, or ~~$0.74~~$0.35 per diluted share, compared to income from continuing operations of ~~$17.0~~$15.3 million, or ~~$0.53~~$0.49 per diluted share, for the first ~~nine~~six months of ~~2015.~~2016. The effective tax rates for the first ~~nine~~six months of 2017 and 2016 were 33.0% and ~~2015 were 29.4% and 38.7%~~38.3%, respectively. The 5.3% year-over-year percentage rate decrease was primarily due to excess tax benefits related to stock-based compensation being recognized in the current period as a result of adopting ASU 2016-09 in January 2017.

Net income for the first ~~nine~~six months of ~~2016~~2017 was ~~$22.6~~$9.6 million, compared to net income of ~~$16.9~~$15.0 million for the first ~~nine~~six months of ~~2015.~~2016. Net income per diluted share was ~~$0.72~~$0.31 for the first ~~nine~~six months of ~~2016,~~2017, compared to ~~$0.53~~$0.48 for the first ~~nine~~six months of ~~2015.~~2016. In the ~~third~~first quarter of ~~2016, the Company~~2017, we recognized ~~a non-recurring tax benefit~~an expense of ~~$2.7~~$1.2 million ~~or $0.09 per diluted share,~~ related to ~~the release of previously unrecognized tax benefits upon completing deregistration of~~ a ~~non-U.S. entity.~~legal settlement with Biosig Instruments, Inc. See discussion in "Discontinued Operations" below for additional information.

Discontinued Operations

Results from discontinued operations relate to the disposal of our former Commercial business, which was completed in April 2011. We reached substantial completion of asset liquidation at December 31, 2012. Although there was no revenue related to the Commercial business in either the ~~2016~~2017 or ~~2015~~2016 periods, we continue to have legal and accounting expenses as we work with authorities on final deregistration of each entity, and product liability and other legal expenses associated with product previously sold into the Commercial channel.

During the first quarter of 2017, our litigation with Biosig Instruments, Inc. was settled. The litigation began in 2004 and alleged patent infringement in connection with our incorporation of heart rate monitors into certain cardio products of our former Commercial business. We paid Biosig $1.2 million under the settlement, and the matter was dismissed with prejudice. The settlement was expensed in discontinued operations during the quarter ended March 31, 2017 and paid during the quarter ended June 30, 2017. For additional information, see Notes 2 and 14 to our condensed consolidated financial statements, and Part II, Item 1 to this Form 10-Q.

RESULTS OF OPERATIONS

Results of operations information was as follows (dollars in thousands):


	Three Months Ended September 30,						Change					Three Months Ended June 30,						Change
	2016			2015			$			%		2017			2016			$			%
Net sales	$	80,818		$	70,690		$	10,128		14.3	%	$	77,029		$	78,529		$	(1,500	)	(1.9	)%
Cost of sales	41,601			34,481			7,120			20.6	%	38,651			36,667			1,984			5.4	%
Gross profit	39,217			36,209			3,008			8.3	%	38,378			41,862			(3,484		)	(8.3	)%
Operating expenses:
Selling and marketing	21,394			21,742			(348		)	(1.6	)%	23,628			24,711			(1,083		)	(4.4	)%
General and administrative	6,177			5,505			672			12.2	%	7,315			7,203			112			1.6	%
Research and development	3,435			2,573			862			33.5	%	3,586			3,375			211			6.3	%
Total operating expenses	31,006			29,820			1,186			4.0	%	34,529			35,289			(760		)	(2.2	)%
Operating income	8,211			6,389			1,822			28.5	%	3,849			6,573			(2,724		)	(41.4	)%
Other income (expense):
Interest income	60			61			(1		)			175			68			107
Interest expense	(489		)	(6		)	(483		)			(412		)	(514		)	102
Other, net	211			(15		)	226					110			(136		)	246
Total other income (expense), net	(218		)	40			(258		)
Total other expense, net												(127		)	(582		)	455
Income from continuing operations before income taxes	7,993			6,429			1,564					3,722			5,991			(2,269		)
Income tax expense	148			2,556			(2,408		)			1,156			2,295			(1,139		)
Income from continuing operations	7,845			3,873			3,972					2,566			3,696			(1,130		)
Loss from discontinued operations, net of taxes	(251		)	(145		)	(106		)			(77		)	(166		)	89
Net income	$	7,594		$	3,728		$	3,866				$	2,489		$	3,530		$	(1,041	)


	Nine Months Ended September 30,						Change					Six Months Ended June 30,						Change
	2016			2015			$			%		2017			2016			$			%
Net sales	$	280,275		$	226,624		$	53,651		23.7	%	$	190,281		$	199,457		$	(9,176	)	(4.6	)%
Cost of sales	132,852			105,870			26,982			25.5	%	90,158			91,251			(1,093		)	(1.2	)%
Gross profit	147,423			120,754			26,669			22.1	%	100,123			108,206			(8,083		)	(7.5	)%
Operating expenses:
Selling and marketing	81,284			70,193			11,091			15.8	%	61,293			59,890			1,403			2.3	%
General and administrative	21,611			15,376			6,235			40.6	%	14,801			15,434			(633		)	(4.1	)%
Research and development	10,444			7,259			3,185			43.9	%	7,497			7,009			488			7.0	%
Total operating expenses	113,339			92,828			20,511			22.1	%	83,591			82,333			1,258			1.5	%
Operating income	34,084			27,926			6,158			22.1	%	16,532			25,873			(9,341		)	(36.1	)%
Other income (expense):
Interest income	182			164			18					306			122			184
Interest expense	(1,469		)	(17		)	(1,452		)			(856		)	(980		)	124
Other, net	(49		)	(412		)	363					63			(260		)	323
Total other expense, net	(1,336		)	(265		)	(1,071		)			(487		)	(1,118		)	631
Income from continuing operations before income taxes	32,748			27,661			5,087					16,045			24,755			(8,710		)
Income tax expense	9,621			10,710			(1,089		)			5,294			9,473			(4,179		)
Income from continuing operations	23,127			16,951			6,176					10,751			15,282			(4,531		)
Loss from discontinued operations, net of taxes	(559		)	(67		)	(492		)			(1,169		)	(308		)	(861		)
Net income	$	22,568		$	16,884		$	5,684				$	9,582		$	14,974		$	(5,392	)

Results of operations information by segment was as follows (dollars in thousands):


	Three Months Ended September 30,						Change						Three Months Ended June 30,						Change
	2016			2015			$				%		2017			2016			$				%
Net sales:
Direct	$	33,710		$	42,876		$	(9,166	)		(21.4	)%	$	39,111		$	44,940		$	(5,829	)		(13.0	)%
Retail	46,223			25,730			20,493				79.6	%	37,083			32,911			4,172				12.7	%
Royalty	885			2,084			(1,199		)		(57.5	)%	835			678			157				23.2	%
	$	80,818		$	70,690		$	10,128			14.3	%	$	77,029		$	78,529		$	(1,500	)		(1.9	)%
Cost of sales:
Direct	$	11,579		$	15,326		$	(3,747	)		(24.4	)%	$	14,345		$	14,781		$	(436	)		(2.9	)%
Retail	30,008			19,155			10,853				56.7	%	24,306			21,886			2,420				11.1	%
Royalty	14			—			14				—	%
	$	41,601		$	34,481		$	7,120			20.6	%	$	38,651		$	36,667		$	1,984			5.4	%
Gross profit:
Direct	$	22,131		$	27,550		$	(5,419	)		(19.7	)%	$	24,766		$	30,159		$	(5,393	)		(17.9	)%
Retail	16,215			6,575			9,640				146.6	%	12,777			11,025			1,752				15.9	%
Royalty	871			2,084			(1,213		)		(58.2	)%	835			678			157				23.2	%
	$	39,217		$	36,209		$	3,008			8.3	%	$	38,378		$	41,862		$	(3,484	)		(8.3	)%
Gross margin:
Direct	65.7		%	64.3		%	140			basis points			63.3		%	67.1		%	(380		)	basis points
Retail	35.1		%	25.6		%	950			basis points			34.5		%	33.5		%	100			basis points

Nine Months Ended September 30, Change
2016 2015 $ %
Net sales:
Direct $ 159,884
$ 158,595
$ 1,289
0.8 %
Retail 117,939
64,424
53,515
83.1 %
Royalty 2,452
3,605
(1,153 ) (32.0 )%
$ 280,275
$ 226,624
$ 53,651
23.7 %
Cost of sales:
Direct $ 53,732
$ 56,803
$ (3,071 ) (5.4 )%
Retail 79,087
49,067
30,020
61.2 %
Royalty 33
—
33
— %
$ 132,852
$ 105,870
$ 26,982
25.5 %
Gross profit:
Direct $ 106,152
$ 101,792
$ 4,360
4.3 %
Retail 38,852
15,357
23,495
153.0 %
Royalty 2,419
3,605
(1,186 ) (32.9 )%
$ 147,423
$ 120,754
$ 26,669
22.1 %
Gross margin:
Direct 66.4 % 64.2 % 220
basis points
Retail 32.9 % 23.8 % 910
basis points



	Six Months Ended June 30,						Change
	2017			2016			$				%
Net sales:
Direct	$	113,814		$	126,174		$	(12,360	)		(9.8	)%
Retail	74,888			71,716			3,172				4.4	%
Royalty	1,579			1,567			12				0.8	%
	$	190,281		$	199,457		$	(9,176	)		(4.6	)%
Cost of sales:
Direct	$	40,124		$	42,153		$	(2,029	)		(4.8	)%
Retail	50,023			49,079			944				1.9	%
Royalty	11			19			(8		)		(42.1	)%
	$	90,158		$	91,251		$	(1,093	)		(1.2	)%
Gross profit:
Direct	$	73,690		$	84,021		$	(10,331	)		(12.3	)%
Retail	24,865			22,637			2,228				9.8	%
Royalty	1,568			1,548			20				1.3	%
	$	100,123		$	108,206		$	(8,083	)		(7.5	)%
Gross margin:
Direct	64.7		%	66.6		%	(190		)	basis points
Retail	33.2		%	31.6		%	160			basis points

The following table compares the net sales of our major product lines within each business segment (dollars in thousands):


	Three Months Ended September 30,				Change					Three Months Ended June 30,				Change
	2016		2015		$			%		2017		2016		$			%
Direct net sales:
Cardio products⁽¹⁾	$	30,548	$	39,696	$	(9,148	)	(23.0	)%	$	34,631	$	41,434	$	(6,803	)	(16.4	)%
Strength products⁽²⁾	3,162		3,180		(18		)	(0.6	)%	4,480		3,506		974			27.8	%
	33,710		42,876		(9,166		)	(21.4	)%	39,111		44,940		(5,829		)	(13.0	)%
Retail net sales:
Cardio products⁽¹⁾	33,280		14,670		18,610			126.9	%	27,821		23,506		4,315			18.4	%
Strength products⁽²⁾	12,943		11,060		1,883			17.0	%	9,262		9,405		(143		)	(1.5	)%
	46,223		25,730		20,493			79.6	%	37,083		32,911		4,172			12.7	%

Royalty	885		2,084		(1,199		)	(57.5	)%	835		678		157			23.2	%
	$	80,818	$	70,690	$	10,128		14.3	%	$	77,029	$	78,529	$	(1,500	)	(1.9	)%


	Nine Months Ended September 30,				Change					Six Months Ended June 30,				Change
	2016		2015		$			%		2017		2016		$			%
Direct net sales:
Cardio products⁽¹⁾	$	149,074	$	147,579	$	1,495		1.0	%	$	103,334	$	118,526	$	(15,192	)	(12.8	)%
Strength products⁽²⁾	10,810		11,016		(206		)	(1.9	)%	10,480		7,648		2,832			37.0	%
	159,884		158,595		1,289			0.8	%	113,814		126,174		(12,360		)	(9.8	)%
Retail net sales:
Cardio products⁽¹⁾	86,739		37,908		48,831			128.8	%	56,860		53,459		3,401			6.4	%
Strength products⁽²⁾	31,200		26,516		4,684			17.7	%	18,028		18,257		(229		)	(1.3	)%
	117,939		64,424		53,515			83.1	%	74,888		71,716		3,172			4.4	%

Royalty	2,452		3,605		(1,153		)	(32.0	)%	1,579		1,567		12			0.8	%
	$	280,275	$	226,624	$	53,651		23.7	%	$	190,281	$	199,457	$	(9,176	)	(4.6	)%

⁽¹⁾ Cardio products include: Max Trainer^®,TreadClimber^®, Zero Runner^®, treadmills, exercise bikes and ellipticals.
⁽¹⁾ Cardio products include: Max Trainer^®,TreadClimber^®, HVT™, Zero Runner^®, treadmills, exercise bikes and ellipticals.										⁽¹⁾ Cardio products include: Max Trainer^®,TreadClimber^®, HVT™, Zero Runner^®, treadmills, exercise bikes and ellipticals.
⁽²⁾ Strength products include: home gyms, selectorized dumbbells, kettlebell weights and accessories.	⁽²⁾ Strength products include: home gyms, selectorized dumbbells, kettlebell weights and accessories.									⁽²⁾ Strength products include: home gyms, selectorized dumbbells, kettlebell weights and accessories.

Direct

Direct net sales decreased ~~21.4%~~13.0% and ~~increased 0.8%, respectively,~~9.8% for the three and ~~nine~~six month periods, respectively, ended ~~September~~June 30, ~~2016~~2017 compared to the same periods of ~~2015.~~2016. The decrease in net sales in the third quarter of 2016 was primarily related to a decline in the media response rate for cardio products, resulting in a decision to defer advertising spending during the quarter to ensure a profitable return on media investment. The increasedecreases in net sales for the ~~nine~~three and six month ~~period ended September 30, 2016 was~~periods were primarily related to andeclines in cardio unit sales, primarily the TreadClimber^® product line. The decreases in cardio sales were partially offset by a 27.8% and 37.0% increase in ~~net~~strength products in the three and six month periods, respectively, that resulted from higher sales of ~~our cardio~~home gyms and dumbbell products.

Combined consumer credit approvals by our primary and secondary U.S. third-party financing providers for the ~~third~~second quarter of ~~2016 was 47.9%~~2017 were 52.2%, compared to ~~47.8%~~47.3% in the same period of ~~2015.~~2016. We continue to experience improved credit approval rates due to our media strategy, which focuses on generation of responses from consumers with relatively high credit quality. Additionally, our Tier 1 credit provider has noted strong performance from our account portfolio, and, due to that credit profile, has progressively expanded its approval standards. We remain focused on maintaining a healthy payment balance between cash and financed purchases.

The ~~$3.7~~$0.4 million ~~decrease~~and $2.0 million decreases, respectively, in cost of sales of our Direct business infor the ~~third quarter of 2016~~three and six month periods ended June 30, 2017 compared to the same ~~period~~periods of ~~2015 was~~2016 were due to lower net sales. The $3.1 million decrease in cost of sales in the nine month period ended September 30, 2016 was due to favorable product mix and lower reserve requirements partially offset by the increase in net sales.

For the three and ~~nine~~six month periods ended ~~September~~June 30, ~~2016,~~2017, Direct gross ~~margin increased 140~~margins decreased 380 and ~~220~~190 basis points, respectively, as compared to the same periods of ~~2015~~2016 primarily due to higher discounting of the TreadClimber^®product ~~mix~~line and lower ~~reserve requirements.~~overhead absorption resulting from the lower net sales.

Retail

Retail net sales increased ~~by 79.6%~~12.7% and ~~83.1%, respectively,~~4.4% for the three and ~~nine~~six month periods ended ~~September~~June 30, ~~2016~~2017 compared to the same periods of ~~2015.~~2016. The increases ~~were primarily driven by the acquisition of Octane, as well as organic~~in both periods reflected growth in traditional and e-commerce customers across ~~a variety of cardio and strength products.~~multiple product categories.

The increases in cost of sales of our Retail business for the three and ~~nine~~six month periods ended ~~September~~June 30, ~~2016~~2017 compared to the same periods of ~~2015~~2016 were ~~almost entirely~~primarily related to the ~~growth~~increases in Retail net sales as discussed above.

For the three and ~~nine month periods~~six months period ended ~~September~~June 30, ~~2016,~~2017, Retail gross margin increased ~~950~~by 100 and ~~910~~160 basis points, respectively, compared to the same periods of ~~2015~~2016 due toimprovements in product mix and the ~~inclusion~~reduction of Octane, which has higher margins, along with leveraging of supply chain costs and lower reserve requirements in the organic Retail business. The margin increases for the three and nine month periods of 2016 are net of purchase price accounting-related inventory step-up charges of $0.1 million and $1.1 million, respectively, that are included in cost of sales.certain warranty reserves.

Selling and Marketing


Dollars in thousands	Three Months Ended September 30,		Change		Three Months Ended June 30,		Change
	2016	2015	$	%	2017	2016	$	%
Selling and marketing	$21,394	$21,742	$(348)	(1.6)%	$23,628	$24,711	$(1,083)	(4.4)%
As % of net sales	26.5%	30.8%			30.7%	31.5%


Dollars in thousands	Nine Months Ended September 30,		Change		Six Months Ended June 30,		Change
	2016	2015	$	%	2017	2016	$	%
Selling and marketing	$81,284	$70,193	$11,091	15.8%	$61,293	$59,890	$1,403	2.3%
As % of net sales	29.0%	31.0%			32.2%	30.0%

The ~~$0.3~~$1.1 million decrease in selling and marketing expense in the ~~three month~~three-month period ended ~~September~~June 30, ~~2016~~2017 compared to the same period of ~~2015~~2016 was primarily due to the reversal of a $1.4 million reserve related to ~~lower media advertising of $1.7 million,~~a royalty dispute and lower variable ~~sales~~selling expenses of ~~$1.4~~$0.6 million, ~~and~~ partially offset by ~~incremental selling~~$0.7 million higher creative and marketing expenses related to the inclusion of Octane of $2.5 million. For the nine months ended September 30, 2016, the year-over-year increase was primarily attributable to incremental selling and marketing expenses related to Octane and increased media spend of $7.5 million and $2.6 million, respectively.photography expense for new products.

The ~~decreases~~$1.4 million increase in selling and marketing expense ~~as a percentage of net sales~~ in the ~~three and nine month periods~~six-month period ended ~~September~~June 30, ~~2016 compared~~2017 was related to ~~the same periods~~a $2.6 million increase in media advertising, partially offset by lower marketing program costs of ~~2015 were primarily due to the acquisition of Octane and growth in the organic Retail business, both of which have a lower selling and marketing expense percentage than the company average.~~$0.9 million.

Media advertising expense of our Direct business is the largest component of selling and marketing and was as follows:


Dollars in thousands	Three Months Ended September 30,		Change		Three Months Ended June 30,		Change
	2016	2015	$	%	2017	2016	$	%
Media advertising	$10,790	$12,510	$(1,720)	(13.7)%	$12,587	$12,505	$82	0.7%


Dollars in thousands	Nine Months Ended September 30,		Change		Six Months Ended June 30,		Change
	2016	2015	$	%	2017	2016	$	%
Media advertising	$40,804	$38,211	$2,593	6.8%	$32,590	$30,014	$2,576	8.6%

The ~~decrease~~increases in media advertising in the three and six month ~~period~~periods ended ~~September~~June 30, ~~2016~~2017 compared to the same ~~period~~periods of ~~2015 was primarily related to a decision to defer advertising spending during~~2016 reflected lower response rates that drove the ~~quarter to ensure a profitable return on media investment,~~increased investments in ~~response to a decline in the media response rate for cardio products.~~

~~The increase in media advertising in the nine month period ended September 30, 2016 compared to the same period of 2015 was primarily to drive incremental leads and sales in the Direct business.~~advertising.

General and Administrative


Dollars in thousands	Three Months Ended September 30,		Change		Three Months Ended June 30,		Change
	2016	2015	$	%	2017	2016	$	%
General and administrative	$6,177	$5,505	$672	12.2%	$7,315	$7,203	$112	1.6%
As % of net sales	7.6%	7.8%			9.5%	9.2%


Dollars in thousands	Nine Months Ended September 30,		Change		Six Months Ended June 30,		Change
	2016	2015	$	%	2017	2016	$	%
General and administrative	$21,611	$15,376	$6,235	40.6%	$14,801	$15,434	$(633)	(4.1)%
As % of net sales	7.7%	6.8%			7.8%	7.7%

The increase in general and administrative infor the three ~~month period~~months ended ~~September~~June 30, ~~2016~~2017 compared to the same period of ~~2015~~2016 was primarily due to ~~the addition~~higher litigation spending of ~~Octane of $1.1 million and amortization of Octane acquired assets of $0.8~~$0.6 million, partially offset by $0.3 million lower ~~patent~~stock compensation expense and ~~legal charges~~$0.1 million lower amortization expense.

The decrease in general and ~~a reduction in employee incentive compensation costs of $0.7 million and $0.6 million, respectively. For~~administrative for the ~~nine~~six months ended ~~September~~June 30, ~~2016~~2017 compared to the same period of ~~2015, the increase~~2016 was ~~attributable~~primarily due to ~~the inclusion~~lower employee incentives and compensation costs of ~~the Octane business~~$1.1 million, and $0.3 million savings related to lower integration costs of Octane. These costs were partially offset by higher litigation expenses of $0.9 million in the amount of $2.9 million, amortization of Octane acquired assets of $2.3 million, acquisition-related consulting expenses of $0.5 million, and non-recurrence of a state business tax refund of $0.5 million received in the second quarter of 2015.

~~The increase in general and administrative as a percentage of net sales in the nine month period ended September 30, 2016 compared to the~~ same ~~period of 2015 was due to the inclusion of Octane and other increased spending as discussed above.~~comparative period.

Research and Development


Dollars in thousands	Three Months Ended September 30,		Change		Three Months Ended June 30,		Change
	2016	2015	$	%	2017	2016	$	%
Research and development	$3,435	$2,573	$862	33.5%	$3,586	$3,375	$211	6.3%
As % of net sales	4.3%	3.6%			4.7%	4.3%


Dollars in thousands	Nine Months Ended September 30,		Change		Six Months Ended June 30,		Change
	2016	2015	$	%	2017	2016	$	%
Research and development	$10,444	$7,259	$3,185	43.9%	$7,497	$7,009	$488	7.0%
As % of net sales	3.7%	3.2%			3.9%	3.5%

The increases in research and development in the three and ~~nine~~six month periods ended ~~September~~June 30, ~~2016~~2017 compared to the same periods of ~~2015~~2016 were primarily due to our investment in additional engineering and product development headcount as we continue to supplement our new product development resources required to innovate and broaden our product ~~portfolio, coupled with the incremental impact of the research and development expenses related to Octane.~~

The increases in research and development as a percentage of net sales in the three and nine month periods of 2016 compared to the same periods of 2015 were primarily due to the increased investment discussed above.portfolio.

Interest Expense

Interest expense ~~increased $0.5~~of $0.4 million and ~~$1.5~~$0.9 million ~~respectively,~~ for the three and ~~nine~~six month periods ended ~~September~~June 30, ~~2016~~2017 decreased $0.1 million and $0.1 million, respectively, compared to the same periods of ~~2015~~2016. The decreases were due to ~~borrowings under~~reductions in principal balance on our term ~~loan in connection with the Octane acquisition on December 31, 2015.~~loan.

Other, Net

Other, net relates to the effect of exchange rate fluctuations between the U.S. and our foreign subsidiaries, primarily Canada, China and Europe.

Income Tax Expense


Dollars in thousands	Three Months Ended September 30,		Change		Three Months Ended June 30,		Change
	2016	2015	$	%	2017	2016	$	%
Income tax expense	$148	$2,556	$(2,408)	(94.2)%	$1,156	$2,295	$(1,139)	(49.6)%
Effective tax rate	1.9%	39.8%			31.1%	38.3%


Dollars in thousands	Nine Months Ended September 30,		Change		Six Months Ended June 30,		Change
	2016	2015	$	%	2017	2016	$	%
Income tax expense	$9,621	$10,710	$(1,089)	(10.2)%	$5,294	$9,473	$(4,179)	(44.1)%
Effective tax rate	29.4%	38.7%			33.0%	38.3%

The decreases in ~~income~~the effective tax ~~expense~~rates from continuing operations for the three and ~~nine~~six month periods ended ~~September~~June 30, ~~2016~~2017 compared to the same periods of ~~2015~~2016 were primarily ~~attributed~~due to ~~the release~~$0.2 million and $0.7 million of ~~previously unrecognized~~excess tax benefits, ~~associated with certain non-U.S. filing positions. These resulted~~respectively, related to stock-based compensation recognized as a current period benefit through the statement of operations, resulting from ~~completion~~adoption of ~~the deregistration process of a certain foreign entity during the third quarter of 2016.~~ASU 2016-09 in January 2017.

LIQUIDITY AND CAPITAL RESOURCES

As of ~~September~~June 30, ~~2016~~2017, we had ~~total~~$85.4 million of cash and investments ~~of $59.3 million~~ compared to ~~$60.8~~$79.6 million as of December 31, ~~2015.~~2016. Cash provided by operating activities was ~~$14.9~~$17.9 million for the ~~nine~~six months ended ~~September~~June 30, ~~2016~~2017, compared to ~~$18.5~~$23.0 million for the ~~nine~~six months ended ~~September~~June 30, ~~2015.~~2016. We expect our cash, cash equivalents and available-for-sale securities at ~~September~~June 30, ~~2016,~~2017, along with cash expected to be generated from operations, to be sufficient to fund our operating and capital requirements for at least twelve months from ~~September~~June 30, ~~2016.~~2017.

The decrease in cash flows from operating activities for the ~~nine~~six months ended ~~September~~June 30, ~~2016~~2017 as compared to the same period of ~~2015~~2016 was primarily due to the decline in operating performance, partially offset by changes in our operating assets and liabilities as discussed ~~below, partially offset by improved operating performance.~~below.

Trade receivables decreased ~~$13.9~~$21.2 million to $~~31.3~~24.2 million as of ~~September~~June 30, ~~2016,~~2017, compared to ~~$45.2~~$45.5 million as of December 31, ~~2015,~~2016, due to seasonally lower net sales in the Retail business. Trade receivables as of ~~September~~June 30, 2017 compared to June 30, 2016 ~~compared to September 30, 2015~~ increased ~~$12.2~~$4.6 million due to the ~~acquisition of Octane.~~increase in Retail net sales.

Inventories ~~increased $6.5~~decreased $4.7 million to ~~$49.2~~$42.3 million as of ~~September~~June 30, ~~2016,~~2017, compared to ~~$42.7~~$47.0 million as of December 31, ~~2015~~2016 due to ~~seasonal preparations for the coming fourth quarter.~~seasonally lower sales. Inventories as of ~~September~~June 30, 2017 compared to June 30, 2016 ~~compared to September 30, 2015 increased~~decreased by ~~$13.7 million, primarily due to the acquisition of Octane.~~

Net deferred income tax liability increased $3.9 million to $13.4 million as of September 30, 2016, compared to $9.5 million as of December 31, 2015, primarily due to the utilization of tax credit carryforwards from prior periods.$0.7 million.

Trade payables decreased ~~$17.0~~$19.1 million to $~~44.8~~46.9 million as of ~~September~~June 30, ~~2016,~~2017, compared to ~~$61.7~~$66.0 million as of December 31, ~~2015,~~2016, due to seasonality inof the business. Trade payables as of ~~September~~June 30, 2017 compared to June 30, 2016 ~~compared to September 30, 2015~~ increased ~~$5.9~~$3.7 million. The higher amount outstanding as of ~~September~~June 30, ~~2016~~2017 was ~~primarily~~ due to ~~addition~~timing of ~~the Octane business.~~vendor payments.

Accrued liabilities decreased ~~$3.6~~$4.1 million to ~~$9.4~~$8.7 million as of ~~September~~June 30, ~~2016,~~2017, compared to ~~$13.0~~$12.9 million as of December 31, ~~2015,~~2016, due to settlement of a ~~reduction in accrued incentive compensation~~royalty dispute in the ~~first nine months~~second quarter of ~~2016, reflecting~~2017, and payout of accrued incentive compensation during the first ~~quarter.~~quarter of 2017.

Cash used in investing activities of ~~$4.8~~$32.9 million for the first ~~nine~~six months of ~~2016~~2017 was primarily related to ~~$3.5 million of payments to Octane under the December 31, 2015 stock purchase agreement, partially offset by~~ net ~~maturities~~purchases of marketable securities of ~~$1.9~~$31.8 million. In addition, ~~$3.2~~$1.1 million was used for capital expenditures ~~during the period~~ primarily ~~for~~related to production equipment tooling and ~~computer hardware and software.~~implementation of new software systems. We anticipate spending between ~~$5.0~~$6.0 million and ~~$6.0~~$7.0 million in ~~2016~~2017 for software, equipment, and product tooling.

Cash used in financing activities of ~~$9.8~~$11.7 million for the first ~~nine~~six months of ~~2016~~2017 was primarily related to principal repayments on our term loan of ~~$12.0~~$8.0 million ~~partially offset by $1.9 million~~and share repurchases of ~~recognized excess tax benefits related to stock-based compensation.~~

$3.4 million.

Financing Arrangements

We have a Credit Agreement with JPMorgan Chase Bank, N.A. (“Chase Bank”) that provides for an $80.0 million term loan and a $20.0 million revolving line of credit. The term of the Credit Agreement expires on December 31, 2020 and is secured by substantially all of our assets.

The Credit Agreement, as amended, contains customary covenants, including minimum fixed charge coverage ratio and funded debt to EBITDA ratio, and limitations on capital expenditures, mergers and acquisitions, indebtedness, liens, dispositions, dividends and investments. The Credit Agreement also contains customary events of default. Upon an event of default, the lender may terminate its credit line commitment, accelerate all outstanding obligations and exercise its remedies under the continuing security agreement.

Borrowing availability under the revolving line of credit is subject to our compliance with certain financial and operating covenants at the time borrowings are requested. Letters of credit under the Credit Agreement are treated as a reduction of the available borrowing amount and are subject to covenant testing.

The interest rate applicable to the term loan, as well as each advance under the revolving line of credit, is based on either Chase Bank's floating prime rate or adjusted LIBOR, plus an applicable margin. As of ~~September~~June 30, ~~2016~~2017 our borrowing rate for both the term loan and line of credit advances was ~~1.77%~~2.29%.

As of ~~September~~June 30, ~~2016,~~2017, the balance on our term loan was ~~$68.0~~$56.0 million, and we had no outstanding borrowings under the line of credit. ~~In addition, $0.6 million in letters of credit that expire in April 2017 were outstanding under the Credit Agreement.~~ As of ~~September~~June 30, ~~2016,~~2017, we were in compliance with the financial covenants of the Credit Agreement and ~~approximately $19.4~~$20.0 million was available for borrowing under the line of credit.

As of ~~September~~June 30, ~~2016,~~2017, we had a ~~$68.0~~$56.0 million receive-variable, pay-fixed interest rate swap outstanding with Chase Bank. The interest rate swap amortizes monthly in line with the outstanding principal balance on our term loan and is classified as a cash flow hedge. The swap matures on December 31, 2020 and has a fixed rate of 1.42% per annum. The variable rate on the interest rate swap is the one-month LIBOR benchmark. At ~~September~~June 30, ~~2016,~~2017, the one-month LIBOR rate was ~~0.52%~~1.04%.

Commitments and Contingencies

For a description of our commitments and contingencies, refer to Note 1514 to our ~~Condensed Consolidated Financial Statements~~condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q.

Off-Balance Sheet Arrangements

In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from our use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

The nature and terms of these indemnifications vary from contract to contract, and generally a maximum obligation is not stated. We hold insurance policies that mitigate potential losses arising from certain types of indemnifications. ~~Because we are unable to estimate our potential obligation, and because management~~Management does not ~~expect~~deem these obligations to ~~have a material adverse effect on~~be significant to our ~~consolidated~~ financial position, results of operations or cash flows, and therefore, no liabilities ~~are~~were recorded at ~~September~~June 30, ~~2016.~~2017.

Stock Repurchase Program

As of ~~September~~June 30, ~~2016, we have repurchased 711,708 shares at an average price of $16.25~~ ~~per share for a total of$11.6 million, and $13.4 million remained available for future repurchases.~~ ~~The repurchase program expires on November 3, 2016 as to the approximately $3.4~~2017, there was $19.6 million remaining available for repurchases under the ~~original $15.0 million authorization. The~~share repurchase ~~program expires on May 4, 2018 as to the $10.0 million available for repurchases under the $10.0 million expansion.~~programs.

SEASONALITY

We expect our sales from fitness equipment products to vary seasonally. Sales are typically strongest in the first and fourth quarters, followed by the third quarter, and are generally weakest in the second quarter. We believe that, during the spring and summer months, consumers tend to be involved in outdoor activities, including outdoor exercise, which impacts sales of indoor fitness equipment. This seasonality can have a significant effect on our inventory levels, working capital needs and resource utilization.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our critical accounting policies have not changed from those discussed in our ~~2015~~2016 Form 10-K.

NEW ACCOUNTING PRONOUNCEMENTS

See Note 1 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 for a discussion of new accounting pronouncements.


Item 3.	Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

Our exposure to market risk from changes in interest rates relates primarily to our cash equivalents, marketable securities, derivative assets and variable-rate debt ~~obligations, and derivative liabilities.~~obligations. As of ~~September~~June 30, ~~2016,~~2017, we had cash equivalents of ~~$5.5~~$9.8 million held in a combination of money market funds and commercial paper, and marketable securities of ~~$28.1~~$63.6 million, held in a combination of certificates of deposit, commercial paper, corporate bonds, and U.S. government bonds. Our cash equivalents mature within three months or less from the date of purchase. Marketable securities with original maturities of greater than three months and remaining maturities of less than one year are classified as short-term investments. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations. We have classified our marketable securities as available-for-sale and, therefore, we may choose to sell or hold them as changes in the market occur. Because of the short-term nature of the instruments in our portfolio, a decline in interest rates would reduce our interest income over time, and an increase in interest rates may negatively affect the market price or liquidity of certain securities within the portfolio, but a change in interest rates would not have a material impact on our results of operations, financial position or cash flows.

Our negotiated credit facilities generally charge interest based on a benchmark rate such as LIBOR. Fluctuations in short-term interest rates may cause interest payments on term loan principal and drawn amounts on the revolving line to increase or decrease. As of ~~September~~June 30, ~~2016,~~2017, the outstanding balances on our credit facilities totaled ~~$68.0~~$56.0 million.

~~In January 2016,~~As of June 30, 2017, we ~~entered into an $80.0~~had a $56.0 million receive-variable, pay-fixed interest rate swap ~~agreement, amortizing~~outstanding with Chase Bank, which amortizes monthly in line with the outstanding principal balance on our term loan. The swap is classified as a cash flow hedge and effectively fixes the interest rate on our variable-rate term loan. The interest rate swap matures on December 31, 2020 and has a fixed interest rate of 1.42% per annum. The variable rate on the interest rate swap is the one-month LIBOR benchmark, which was ~~0.52%~~1.04% at ~~September~~June 30, ~~2016.~~2017.

The fair value of our interest rate swap agreement represents the estimated receipts or payments that would be made to terminate the agreement. The amounts related to our cash flow hedge are recorded as deferred gains or losses in our ~~Consolidated Balance Sheets~~consolidated balance sheets with the offset recorded in accumulated other comprehensive income, net of tax. At ~~September~~June 30, ~~2016,~~2017, the fair value of our interest rate swap agreement was ~~a liability~~an asset of ~~$0.9~~$0.1 million. The estimated amount expected to be reclassified into earnings within the next twelve months was ~~$0.6~~$0.1 million at ~~September~~June 30, ~~2016.~~2017.

We do not enter into derivative instruments for any purpose other than to manage our interest rate exposure. That is, we do not engage in interest rate speculation using derivative instruments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15 of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a- 15(e) and Rule 15d-15(e) under the Exchange Act). Based upon their evaluation of these disclosure controls and procedures, our management, including the Chief Executive Officer and Chief Financial Officer, have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting

At this time, we continue to evaluate the business and internal controls and processes associated with Octane and are making various changes to its operating and organizational structure based on our business plan. We are implementing an ERP system and complementary systems that support our Retail operations related to Octane. During the second quarter ended June 30, 2017, the requirements phase of the ERP integration was approved and technical design and updated project plan were in progress. We expect to develop and deploy features of the ERP and complementary systems beginning in the ~~process~~third quarter of ~~implementing our internal control structure over this acquired business. The SEC’s rules require us~~2017 with full implementation planned to ~~include acquired entities in our assessment~~be completed by second quarter of 2018. As each phase of the ~~effectiveness of~~implementation occurs, we are taking steps to monitor and maintain appropriate internal control over financial reporting ~~no later than the annual management report following the first anniversary of the acquisition. We plan~~and will continue to complete the evaluation and the integration of Octane within the required time frames and report management’s assessment of our internal control over financial reporting in our first annual report in which such assessment is requiredevaluate these controls for ~~this acquisition.~~effectiveness.

There were no other changes in our internal control over financial reporting that occurred during the three months ended ~~September~~June 30, ~~2016~~,2017, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION


Item 1.	Legal Proceedings

Patent Infringement Case

~~were invalid as a matter of law. BioSig appealed the grant of summary judgment~~settlement, and ~~in April 2013, the United States Court of Appeals for the Federal Circuit reversed the District Court’s decision on summary judgment and remanded the case to~~ the District Court ~~for further proceedings. On January 10, 2014,~~dismissed the ~~U. S. Supreme Court granted our petition for a writ of certiorari to address~~suit with prejudice. The settlement was expensed in discontinued operations during the ~~legal standard applied by~~quarter ended March 31, 2017 and paid during the ~~Federal Circuit in determining whether the patents may be valid under applicable law. The case was argued before the Supreme Court on April 28, 2014. By decision dated~~quarter ended June 2, 2014, the Supreme Court unanimously reversed the Federal Circuit, holding that its standard of when a patent may be “indefinite” was incorrect and remanding to the Federal Circuit for reconsideration under the correct standard. The remand hearing in the Federal Circuit was held on October 29, 2014. By decision dated April 27, 2015, the same panel of the Federal Circuit affirmed its earlier reversal of the District Court’s decision on summary judgment. On May 27, 2015, we filed a petition for a rehearing en banc in the Federal Circuit, which was denied on August 4, 2015 and a Petition for Review by the U. S. Supreme Court which was also denied. The case has been returned to the District Court, and the parties are currently engaged in discovery and other pre-trial motion practice. We do not believe that our use of heart rate monitors utilized or purchased from third parties, and otherwise, infringes the BioSig patents.30, 2017.

In addition to the matter described above, from time to time, we ~~are subject~~may be involved in various claims, lawsuits and other proceedings. These legal and tax proceedings involve uncertainty as to ~~litigation, claims~~the eventual outcomes and ~~assessments that arise in the ordinary course of business, including disputes that~~losses which may arise from intellectual property related matters. Management believes that any liability resulting from such additional matters will not have a material adverse effect on our financial position, results of operationsbe realized when one or ~~cash flows.~~more future events occur or fail to occur.

Item 1A. Risk Factors

We operate in an environment that involves a number of risks and uncertainties. The risks and uncertainties described in our ~~2015~~2016 Form 10-K are not the only risks and uncertainties that we face. Additional risks and uncertainties that presently are not considered material or are not known to us, and therefore are not mentioned herein, may impair our business operations. If any of the risks described in our ~~2015~~2016 Form 10-K actually occur, our business, operating results and financial position could be adversely affected. There has not been a material change to the risk factors as set forth in our ~~2015~~2016 Form 10-K.

Item 6. Exhibits

The following exhibits are filed herewith and this list is intended to constitute the exhibit index:



Exhibit No.		Description

31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		The following financial statements from Nautilus, Inc.'s quarterly report on Form 10-Q for the three and ~~nine~~six months ended ~~September~~June 30, ~~2016~~2017 formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets (unaudited), (ii) Condensed Consolidated Statements of Operations (unaudited), (iii) Condensed Consolidated Statements of Comprehensive Income (unaudited), (iv) Condensed Consolidated Statements of Cash Flows (unaudited) and (v) Notes to Condensed Consolidated Financial Statements (unaudited).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



	NAUTILUS, INC.
	(Registrant)

~~November~~August 3, ~~2016~~2017	By:	/S/ Bruce M. Cazenave
Date		Bruce M. Cazenave
		Chief Executive Officer (Principal Executive Officer)



	NAUTILUS, INC.
	(Registrant)

~~November~~August 3, ~~2016~~2017	By:	/S/ Sidharth Nayar
Date		Sidharth Nayar
		Chief Financial Officer (Principal Financial and Accounting Officer)

3129



	Preliminary valuation at December 31, 2015		Measurement period adjustments			Adjusted preliminary valuation at September 30, 2016
Cash	$	7,759	$	—		$	7,759
Accounts receivable	12,507		—			12,507
Inventories	12,168		1,515			13,683
Prepaid expenses	1,028		(143		)	885
Deferred tax assets	1,287		(527		)	760
Property, plant and equipment	3,240		132			3,372
Intangible assets	63,100		—			63,100
Total assets acquired	101,089		977			102,066

Accounts payable	6,215		282			6,497
Accrued liabilities	1,614		(8		)	1,606
Warranty obligations	5,550		—			5,550
Deferred tax liabilities, non-current	20,914		98			21,012
Other non-current liabilities	519		(129		)	390
Total liabilities assumed	34,812		243			35,055

Net identifiable assets acquired	66,277		734			67,011
Goodwill	58,357		(63		)	58,294
Net assets acquired	$	124,634	$	671		$	125,305



	Estimated fair value		Estimated useful life (years)	Weighted-average amortization period (years)
Trade name - Octane Fitness	$	23,000	Indefinite	N/A

Trade name - others	2,600		10 - 15	12.5
Patents	12,800		11 - 24	18
Customer relationships	24,700		10 - 15	13
Definite-lived intangible assets	40,100
Total intangible assets	$	63,100



	Facilities Leases
Balance, December 31, 2015	$	300
Payments	(225		)
Balance, September 30, 2016	$	75